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Acknowledgements 
Welcome to the fourth Very Low Birth 
Weight Infants in the Republic of Ireland 
(ROI) Annual Report, produced by the 
Neonatal Intensive Care Outcomes 
Research and Evaluation (NICORE) ROI 
group and facilitated by the National 
Perinatal Epidemiology Centre (NPEC). This 
report focuses on all babies born ≤1500g 
and/or ≤29 weeks gestation in the Republic 
of Ireland for the calendar year 2017 and 
compares outcomes to the preceding three 
years.
Data on every Very Low Birth Weight 
(VLBW) infant born in the ROI during the 
years 2014 to 2017 is now available: this 
is over 2,000 infants and is a remarkable 
achievement, made all the more pertinent 
by the fact that we are one of very few 
countries reviewing outcomes of care of 
VLBW infants at a national level. 
Last year, we published our “Mortality Risk 
amongst Very Low Birth Weight Infants 
born in the Republic of Ireland Report, 
2014-2016”, a cumulative report based 
on three years of data and one which the 
National Advisory Group of the Royal 
College of Physicians of Ireland (RCPI), 
the Obstetric Working Group of the Health 
Service Executive (HSE) and the Faculty 
of Paediatrics of the RCPI had asked us 
to undertake. This report has now been 
forwarded to the Expert group established 
by the HSE Clinical Care Programme in 
Paediatrics and Neonatology whose remit 
is to examine issues surrounding infants 
born at the limits of viability. We await the 
deliberations of this Expert group. 
The current focus of the NICORE ROI 
group is to see if we can link our national 
VLBW database with detailed 2 year 
neurodevelopmental follow up. While 
we now have very detailed national 
information on mortality rates at each 
gestational age and birthweight category, 
this is no longer adequate. Families 
facing the imminent delivery of a very 
premature baby, particularly an infant born 
at the limits of viability, need accurate 
and up to date information not only on 
the chances of survival but, perhaps 
even more importantly, on the long term 
neurodevelopmental outcome. Without this 
information, how can clinicians adequately 
counsel families nor how can families make 
informed decisions? A Bayley Assessment 
of Infant Development at 2 years of age 
remains the gold standard in neonatology. 
Recent discussions among our NICORE 
member centres indicate that, in the 
vast majority of cases, even in the larger 
tertiary neonatal centres, there is neither 
the staff nor the financial resources to 
undertake this vital work. This is not just 
about accumulating good outcome data 
so that we can expand our yearly report, 
what is even more important is that these 
vulnerable infants who are at high risk of 
long term neurodevelopmental problems 
are diagnosed as early as possible and 
referred to community based Early 
Intervention Services as soon as possible. 
Premature infants and their families should 
not have to wait until difficulties arise as 
the child progresses through school. We 
are currently in the process of compiling a 
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the HSE to ask them to support this very 
important initiative. 
This report is based on data submitted 
by all 19 neonatal centres in the ROI. It 
would not come to fruition without the 
many neonatal nurses, paediatricians and 
administration staff who have supported 
the data collection process and we 
gratefully acknowledge the commitment 
of all those individuals. We thank the team 
at Vermont Oxford Network who continue 
to whole-heartedly support this initiative 
by working closely with the NPEC on 
data collection and statistical analysis. We 
thank the National Office of Clinical Audit 
(NOCA) for their continuing support to 
NPEC in ensuring that recommendations 
arising from national clinical audit are 
reviewed and actioned: this report, similar 
to previous reports, is endorsed by 
NOCA (Appendix A). Lastly, we extend 
our sincere thanks to the NPEC, led by 
Professor Richard Greene, for its continued 
support of the ROI’s participation in 
VON, specifically by financing the annual 
membership fee on behalf of all 19 centres 
and for providing the logistical support 
required to oversee this project. 
To our fellow members of the NICORE ROI 
group, we appreciate their support of this 
project from the onset and for working 
together with us on this new initiative to 
see if we can expand our collection of data 
to include neurodevelopmental outcome: 
the membership of NICORE ROI is listed in 
Appendix B. 
On a final note, this initiative of the ROI 
neonatal community to review its outcomes 
of care at both local and national levels 
demonstrates its commitment to improving 
outcomes for all VLBW infants in the ROI 
and their families. By continuing to assess 
the outcomes of care, learning from the 
data and working together, we have great 
potential to improve the outcomes of 
VLBW infants in Ireland.
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1.  A total of 612 very low birth weight (VLBW) 
infants were born in the Republic of Ireland 
(ROI) in 2017, of which 16 infants had a 
birthweight >1500g but were ≤29 weeks 6 
days gestation.
2.  In all, 238 infants were born with a birth 
weight ≤1000g and 163 infants were born 
with a gestational age ≤26 weeks 6 days.
3.  The crude survival rate for ROI VLBW infants 
in 2017 was 82% (n=501), 4% lower than the 
rate (86%) for all infants reported to the 
Vermont Oxford Network (VON) in the same 
year.
4.  Adjusting for the risk profile of the VLBW 
population, the risk of mortality remains 
higher in the VLBW ROI population in 2017 
(SMR=1.19; 95% CI: 0.96, 1.42) but this finding 
was not statistically significant. This finding is 
consistent with previous years. 
5.  Similarly, the risk of mortality excluding 
early deaths (deaths in the delivery room or 
deaths within 12 hours of admission to the 
NICU) in the VLBW ROI infants is also higher 
in 2017 (SMR=1.20; CI 0.93, 1.48), but again, 
this finding was not statistically significant. 
6.  There is no significant difference in the 
risk of death or morbidity for ROI infants 
compared to VON infants in 2017 (SMR=1.01, 
95% CI: 0.89, 1.14). This is in contrast to 
the two preceding years when ROI infants 
had significantly higher rates of death or 
morbidity.
7.  Again, adjusting for the risk profile of 
the VLBW population, Key Performance 
Indicators in the neonatal care of VLBW 
infants born in the ROI in 2017 compared to 
VON infants showed that:
 •  ROI infants had significantly higher rates of 
Pneumothorax (SMR=1.69, 95% CI: 1.29, 2.1). 
 •  ROI infants had significantly lower rates 
of retinopathy of prematurity (SMR=0.72, 
95% CI: 0.54, 0.89). This was also reported 
in previous years. 
 •  There were no significant differences in risk 
of the following outcomes for ROI infants 
compared to VON infants:
  –  Coagulase negative staphylococcus 
infection (SMR=1.16, 95% CI: 0.80, 1.53), 
in line with previous years;
  –  Nosocomial infection (SMR=1.04, 95% CI: 
0.80, 1.29), similar to 2016 findings; 
  –  Any late infection (SMR=1.03, 95% CI: 
0.78, 1.27), similar to 2016 findings;
  –  Intra-ventricular haemorrhage 
(SMR=0.98, 95% CI: 0.81, 1.15), similar to 
2016 findings; 
  –  Necrotizing enterocolitis (NEC) 
(SMR=1.22, 95% CI: 0.86, 1.59). This is 
in contrast to the two preceding years 
when ROI infants had significantly higher 
rates of NEC.
8.  In 2017, of the 612 infants born, 71% (n=433) 
were born in tertiary neonatal centres; 
18% (n=112) were born in regional neonatal 
centres; and 11% (n=67) were born in 
peripheral centre.
9.  A significantly higher proportion of ROI 
infants died in the delivery room (6%, n=37) 
compared to VON infants (3%, n=1,928) 
(p=0.031) in 2017. This is similar to findings 
in the two earlier years 2016 and 2015. Nine 
(24%) of these 37 ROI infants had a major 
congenital anomaly and 22 (60%) were born 
at less than 24 weeks gestation.
10.  Of all infants born between 23 and 27 weeks 
gestation (n=210), 167 (80%) were born in a 
tertiary neonatal centre, 28 (13%) were born 
in a regional neonatal centre and 15 (7%) 




The Vermont Oxford Network (VON) is a non-profit voluntary collaboration of health care 
professionals dedicated to improving the quality and safety of medical care for newborn 
infants and their families. Established in 1988, the Network is today comprised of more 
than 1200 Neonatal Intensive Care Units around the world (Figure I).
The Network maintains a database of information regarding the care and outcomes of 
high-risk newborn infants. The database provides unique, reliable and confidential data 
to participating units for use in quality management, process improvement, internal audit 
and peer review.
Figure I: Member countries of the Vermont Oxford Network
In the ROI, nine tertiary and regional neonatal centres had joined VON by 2003, followed by 
the remaining 10 centres in 2013. This was on foot of a joint initiative between the NICORE 
group and the NPEC. In 2014, all 19 neonatal centres in the ROI submitted data to VON, 
signifying the first year for which a national dataset is available. The first annual report on all 
VLBW infants born in the Republic of Ireland was subsequently published for the year 2014. 
The current report represents the fourth year, 2017, of a complete ROI dataset.
Member Countries
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Governance
For the ROI, data submitted to VON are 
controlled by NICORE (Neonatal Intensive 
Care Outcomes Research and Evaluation) 
ROI, a group of consultant neonatologists 
and paediatricians with formal representation 
from all 19 tertiary, regional and peripheral 
neonatal centres in the Republic. NICORE ROI 
is formally affiliated through a Memorandum 
of Understanding to the Faculty of 
Paediatrics, Royal College of Physicians of 
Ireland (RCPI). NICORE ROI is also formally 
affiliated to and functions in partnership with 
the National Perinatal Epidemiology Centre 
(NPEC) for the promotion and management 
of VON in the ROI. 
NICORE ROI, incorporating all neonatal 
centres in the Republic, collaborates with 
the five neonatal centres in Northern Ireland 
(NI). This cross-border collaboration has 
been in existence since 2003 when only nine 
centres in the ROI were contributing data to 
VON. The collaborative group at that time 
was identified as NICORE Ireland. When all 
19 centres in the ROI began submitting data 
to VON, the NICORE ROI group was created. 
Effectively, NICORE ROI is a subgroup of 
the parent group, NICORE Ireland. Figure 2 
illustrates all units participating in VON in the 
island of Ireland according to the category of 
their Neonatal Units and the hospital group to 
which they are affiliated.
Figure II: Neonatal 
centres in the Republic 
of Ireland and Northern 
Ireland participating in the 
Vermont Oxford Network. 
ROI centres are classified 
according to category of 
Neonatal Units and the 




In 2017, 19 neonatal centres participated in the VON’s Very Low Birth Weight (VLBW) 
database. The definition of eligibility for the VLBW database is:
Any infant who is born alive at a ROI hospital and whose birth weight is between 401 
and 1500 grams OR whose gestational age is between 22 weeks 0 days and 29 weeks 
6 days (inclusive), regardless of where in the hospital the infant receives care.
Anonymised data on VLBW infants born between 1st January and 31st December 2017 
were submitted to VON’s on-line database or alternatively by paper format to the 
NPEC. (Please see Appendix C for data collection forms). Figure III illustrates the flow of 
information involved. 
Figure III: Flow of information in the VON data collection process
On completion of all ROI submissions for 2017, VON forwarded a copy of the complete 
ROI dataset to the NPEC. The ROI data presented in this report are based on the ROI 
dataset. Throughout the report, ROI data are compared to VON data, comprising data 
from all centres across the Network. The Network data, referred to as VON data, are 
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Case Ascertainment
The VON database allows the capture of a data 
record from the birth centre of all VLBW infants. 
It also allows the capture of a record from the 
first centre to which an infant was transferred, 
where applicable. In cases of infants who were 
treated in more than two centres, the VON 
database does not capture a record from the 
second transfer centre, and thus these infants 
have two records only, one from the birth centre 
and the other from the first transfer centre. On 
receipt of the ROI 2017 dataset from VON, the 
NPEC undertook a matching exercise in order 
to link data records associated with individual 
infants who were transferred (matching the 
record of the unit where the infant was born with 
the record of the unit to where the infant was 
transferred) in order to ensure that each infant 
was counted only once.
Secondly, for the purpose of completion of data, 
in order to ensure that all infants which met the 
VLBW inclusion criteria in 2017 were captured in 
the dataset, the dataset was cross-checked with 
the NPEC’s National Clinical Audit of Perinatal 
Mortality 2017 dataset. Early neonatal deaths, 
between 401g and 1500g or whose gestational 
age was between 220/7 and 296/7, even if 
never admitted to an NICU/SCBU, are eligible 
for reporting to VON. In cases of early neonatal 
deaths which met the VON criteria but were 
not captured in the VON dataset, the relevant 
neonatal centre was requested to complete 
and submit a record. The ROI dataset was 
subsequently updated.
Statistical analysis
Differences in proportions were assessed by 
the two-sample test of proportions. Pearson’s 
chi-squared test (χ2) was used to evaluate the 
association between outcomes and gestational 
age categories. Poisson regression was used to 
assess trend.
Reference to Very Low Birth Weight Infants in 
the Republic of Ireland Annual Report 2014 and 
2015
Since publication of the 2014 and 2015 reports, 
the matching exercise described above was 
undertaken on the 2014 ROI dataset. This had 
the effect of reducing the number of VLBW 
infants born in the ROI in 2014 from 608, as 
described in the 2014 and 2015 reports, to 597. 
The current report utilises the most accurate 
values for 2014 ROI data and hence differs 
slightly from the values stated in the 2014 and 
2015 reports. Values for 2015 data have not 
changed since publication of the 2015 report. 
Reliability of conclusions based on small 
numbers
Population rates and percentages are subject 
to random variation. This variation may be 
substantial when the measure, such as a rate, 
has a small number of events in the numerator 
or denominator. Typically, rates based on large 
numbers provide stable estimates of the true, 
underlying rate. Conversely, rates based on 
small numbers may fluctuate dramatically from 
year to year, or differ considerably from one 
centre to another, even when differences are not 
meaningful. Meaningful analysis of differences 
in rates between geographic areas or over time 
requires that the random variation be quantified 
and that multiple years of data be incorporated. 
It is correct to present rates which are based 
on rare outcomes and small numbers as this is 
what the data shows, but conclusions cannot be 




Any Late Infection: Indicates whether the 
infant has either any late bacterial infection, 
coagulase negative infection and/or fungal 
infection after day 3 of life.
Any Intraventricular Haemorrhage (IVH): 
Indicates whether the infant has a grade 
1, 2, 3 or 4 periventricular-intraventricular 
hemorrhage (PIH) on or before day 28.
Birth weight: Weight from the labour and 
delivery record. If this is unavailable, weight 
on admission to the neonatal unit or lastly, 
the weight obtained on autopsy (if the 
infant expired within 24 hours of birth).
Chronic Lung Disease (CLD): Based on 
an algorithm that was tested with hospital 
data and is more accurate than just oxygen 
dependency at 36 weeks gestational age. 
CLD is coded ‘yes’ if the infant is in your 
centre at 36 weeks postmenstrual age 
and ‘oxygen at 36 weeks’ is answered 
‘yes’. Infants are considered to ‘be in your 
centre at 36 weeks’ if they have not been 
discharged home on that date or if they 
have been transferred from your centre to 
another centre prior to the date of week 36 
but have been readmitted to your centre 
before discharge home, death or first 
birthday or are not transferred a second 
time before 36 weeks. 
If the infant is discharged home on or after 
34 weeks postmenstrual age but before 36 
weeks, then CLD is equal to the ‘value of 
oxygen at discharge’. The latter is recorded 
as ‘yes’ for infants who went home and were 
on oxygen at the time of discharge. If the 
infant was transferred to another hospital 
on or after 34 weeks postmenstrual age 
but before the date of week 36, then CLD 
is equal to the ‘value of oxygen at the time 
of discharge’ from your institution. Again, 
the latter is recorded as ‘yes’ for infants who 
were transferred and were on oxygen at the 
time of discharge from your centre. 
If the infant is discharged home before 34 
weeks postmenstrual and is not on oxygen 
at the time of discharge, then CLD is coded 
as ‘no’. If the infant is transferred before 34 
weeks postmenstrual age and the infant 
is not on oxygen at discharge, then CLD 
is coded as ‘no’. However, if the infant is 
discharged home or transferred to another 
hospital before 34 weeks postmenstrual 
age, and the infant is on oxygen at the time 
of discharge from our centre, then CLD is 
coded as ‘unknown’.
Chronic Lung Disease (CLD) < 33 weeks 
gestation: The same algorithm applied as 
above but only includes infants < 33 weeks 
gestation. 
Coagulase Negative Infection: Coagulase 
negative staphylococcus recovered from a 
blood culture obtained from either a central 
line or a peripheral blood sample, and/or 
recovered from cerebrospinal fluid obtained 
by lumbar puncture, ventricular tap or 
ventricular drain after day 3 of life AND 
one or more signs of generalized infection 
AND treatment with 5 or more days of 
intravenous antibiotics. 
Cystic Periventricular Leukomalacia 
(PVL): Evidence of cystic periventricular 
leukomalacia on a cranial ultrasound, CT, 
or MRI scan obtained at any time prior to 
discharge.
Death or morbidity: Indicates if an infant 
died or was known to have one or more 
of the following key morbidities: severe 
intraventricular haemorrhage (IVH), 
chronic lung disease (CLD) in infants <33 
weeks, necrotising enterocolitis (NEC), 
pneumothorax, any late infection or cystic 
periventricular leukomalacia (PVL). 
Died in the delivery room: Death of a live 
born baby who was never admitted to the 
NICU, and died in the delivery room or at 
any other location in your hospital within 12 
hours after birth.
12 VERY LOW BIRTH WEIGHT INFANTS IN THE REPUBLIC OF IRELAND ANNUAL REPORT 2017
Fungal Infection: Fungus recovered from a 
blood culture obtained from either a central line 
or a peripheral blood sample after day 3 of life.
Gestational age: The best estimate of 
gestational age in weeks and days using the 
following hierarchy: 
–  obstetric measures based on last menstrual 
period, obstetrical parameters, and prenatal 
ultrasound as recorded in the maternal chart.
–  neonatologist’s estimate based on physical 
criteria, neurologic examination, combined 
physical and gestational ages exam (Ballard or 
Dubowitz), or examination of the lens.
Inborn: Infant delivered at the hospital 
submitting the VON data.
Key Performance Indicators (KPIs): VON 
reports on a number of Key Performance 
Indicators (KPIs) which allow the ROI to 
compare its outcomes to VON as a whole. 
Further information on this is available on 
section 4 of the report (4. Key Performance 
Indicators) on page 18.
Late Bacterial Infection: Bacterial pathogen 
recovered from blood and/or cerebrospinal fluid 
culture obtained after day 3 of life. 
Mortality: Indicates whether the infant died.
Mortality excluding early deaths: Death 
excluding those who died in the Delivery Room 
or within 12 hours of admission to the NICU.
Necrotising Enterocolitis (NEC): NEC 
diagnosed at surgery, at post-mortem 
examination or “clinically and radiographically”. 
To be diagnosed “clinically and 
radiographically”, there has to be at least one 
of the following clinical signs present: bilious 
gastric aspirate or emesis; abdominal distension; 
occult or gross blood in stool AND at least one 
of the following radiographic findings present: 
pneumatosis intestinalis, hepato-biliary air, 
pneumoperitoneum.
Nosocomial Infection: Indicates whether the 
infant has either late bacterial infection and/
or coagulase negative staphylococcal infection 
diagnosed after day 3 of life. 
Outborn: Infant delivered outside the hospital 
submitting the VON data. Any infant requiring 
ambulance transfer is considered outborn.
Pneumothorax: Extra-pleural air diagnosed 
by chest radiograph or needle aspiration 
(thoracentesis).
Retinopathy of Prematurity (ROP): Indicates 
whether the infant has stage 1, 2, 3, 4 or 5 ROP.
Resuscitation: Defined, for the purposes of this 
report, as the administration of any positive 
pressure breaths via a face mask ventilation 
and/or via an endotracheal tube in the delivery 
room or in the initial resuscitation area.
Severe Intraventricular Haemorrhage (IVH): 
Indicates whether the infant has a grade 3 or 
4 periventricular-intraventricular haemorrhage 
(PIH) on or before day 28.
Severe Retinopathy of Prematurity (ROP): 
Indicates whether the infant has stage 3, 4 or 5 
ROP. 
Survival without Specified Morbidities: 
Indicates whether the infant survived with none 
of the following key morbidities: Severe IVH, 
CLD Infants <33 Weeks, NEC, Pneumothorax, 




A total of 612 VLBW infants were reported to 
VON in Ireland in 2017, constituting infants born 
in all 19 maternity centres and their affiliated 
Neonatal Intensive Care Units (NICUs) in the 
Republic of Ireland (ROI). A total of 593 VLBW 
infants were reported in 2016, 622 in 2015 and 
597 in 2014. Overall, 63,956 VLBW infants were 
reported to the VON Network in 2017. 
As shown in table 1.1, outlining the gestational 
age of infants reported in 2017, the highest 
proportion of infants were born in the 27-29 
weeks gestation (39%, n=240). A total of 38 
(6%) infants were born with a gestation below 
24 weeks and 37 (6%) infants were born with 
a gestation of more than 32 weeks. In total, 
8% (51 out of 612) of VLBW infants born in 
2017 had a major congenital anomaly (MCA) 
compared to 9% (54 out of 593 ) in 2016, 7% 
(42 out of 622) in 2015 and 9% (55 out of 596) 
in 2014. 
Table 1.1: Number of cases reported to VON 2014 – 2017 in Ireland, according to gestational age. 
Gestational age
All cases No. of cases with MCA
2014 2015 2016 2017 2014 2015 2016 2017
<24 weeks 41 48 48 38 0 0 3 1
24-26 weeks 114 114 134 125 9 11 12 12
27-29 weeks 235 235 217 240 19 14 20 19
30-32 weeks 159 170 152 172 20 10 15 11
>32 weeks 48 55 42 37 7 7 4 8
Total 597 622 593 612 55 42 54 51
Note: MCA=Major Congenital Anomaly. MCA was unknown for 1 infant in 2014 and 2 infants in 2017. 
In terms of birth weight, 23 infants (4%) weighed ≤500g (Table 1.2), of whom five were ≤401g 
(the lowest birthweight recorded was 345g). The majority of infants (35%; n=217) were born 
with a birthweight >1250g of which 16 infants had a birthweight >1500g. Data for the years 2014 
to 2016 is also included in Table 1.2. 
Table 1.2: Number of cases reported to VON in 2014 – 2017 in Ireland, according to birth weight. 
Birth weight (g)
All cases No. of cases with MCA
2014 2015 2016 2017 2014 2015 2016 2017
<501 26 23 21 23 1 0 1 2
501 – 750 85 100 104 93 3 5 14 8
751 – 1000 115 98 125 122 15 14 11 12
1001 – 1250 154 155 152 157 15 10 14 12
>1250 216 246 191 217 21 13 14 17
Total 596 622 593 612 55 42 54 51
Note: MCA=Major Congenital Anomaly; one infant in 2014 (Birthweight 501-750g) did not have a recorded birth weight. 
MCA was unknown for 1 infant in 2014 and 2 infants in 2017.
14 VERY LOW BIRTH WEIGHT INFANTS IN THE REPUBLIC OF IRELAND ANNUAL REPORT 2017
2. Infant Characteristics
In 2017, ROI and VON groups were relatively 
similar with respect to the proportion of infants 
who received prenatal care and whose mother 
had hypertension. (Table 2.1). 
Characteristics for which there were statistically 
significant differences between these two 
populations included a higher proportion of ROI 
infants exposed to chorioamnionitis (p=0.005), 
receiving antenatal steroids (p<0.001,) receiving 
antenatal magnesium sulphate (p<0.001), 
being one of a multiple gestation (p<0.001) or 
having a major congenital anomaly (p<0.001). 
Statistically significantly fewer ROI infants were 
delivered by C-section (p=0.003) and were 
small for gestational age (p=0.001). 
When comparing these characteristics 
across the four years, from 2014 to 2017, the 
proportion of ROI infants receiving antenatal 
steroids has been steadily increasing and it has 
been statistically significantly higher than VON 
infants throughout all of these years (Table 
2.2). An increase has also been noticed in the 
percentage of women administrated antenatal 
magnesium sulphate, in line with national 
recommendations.(1)
For the past four years, the number of infants 
who were one of a multiple gestation has 
also been statistically higher in Ireland, when 
comparing to the VON population (Table 2.2).
While the proportion of VON infants born with 
MCA has remained stable at 5% across the four 
years, each year, the percentage of ROI infants 
born with MCA remains higher than the value 
recorded for VON (Table 2.2). This difference 
between both populations remains highly 
statistically significant similar to previous years 
(p=0.001; Table 2.2). 
Table 2.1: Infant characteristics in the Republic of Ireland and VON, 2017. 
Characteristic
Republic of Ireland VON
Cases N % N % P-value
Male 294 612 48.0 62,156 50.4 0.227
Prenatal Care 582 597 97.5 61,892 96.0 0.064
Chorioamnionitis 101 581 17.4 61,277 13.4 0.005
Maternal Hypertension 173 589 29.4 61,769 32.6 0.095
Antenatal Steroids 545 599 91.0 61,860 84.4 <0.001
C-Section 408 612 66.7 62,154 72.0 0.003
Antenatal Magnesium Sulphate 420 580 71.0 61,481 59.2 <0.001
Multiple Gestation 209 612 34.2 62,185 26.2 <0.001
Major Congenital Anomaly (MCA) 51 612 8.3 62,145 5.3 0.001
Small for Gestational Age (SGA) 119 609 19.5 62,066 25.2 0.001
Note: N represents all babies for whom the variable applies (the denominator). The P-value refers to the significance of the 
value of the difference between the ROI and VON populations.
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3. Survival
Table 2.2: Infant characteristics in the Republic of Ireland, 2014 - 2017. 
Characteristic





















Male 55 51 0.036 54 51 0.132 52 51 0.481 48 50 0.227
Prenatal Care 99* 95 <0.001 98* 96 0.005 96 96 0.737 98 96 0.064
Chorioamnionitis 17* 13 0.013 14 13 0.354 17* 13 0.003 17* 13 0.005
Maternal 
Hypertension
26* 30 0.020 26* 31 0.012 29 32 0.302 29 33 0.095
Antenatal 
Steroids
86* 80 <0.001 88* 81 <0.001 89* 83 <0.001 91* 84 <0.001
C-Section 70 71 0.501 70 72 0.185 69 72 0.174 67* 72 0.003
Antenatal Mag. 
Sulphate
52 52 0.824 59 55 0.076 60 57 0.110 71* 59 <0.001
Multiple 
Gestation
33* 28 0.004 36* 27 <0.001 33* 27 <0.001 34* 26 <0.001
Major Congenital 
Anomaly 
9* 5 <0.001 7* 5 0.045 9* 5 <0.001 8* 5 0.001
Small for 
Gestational Age 
26 24 0.390 24 24 0.946 23 25 0.317 20* 25 0.001
Note: The P-value refers to the significance of the value of the difference between the ROI and VON populations.  
* indicates values statistically significant (p<0.05). 
In 2017, a total of 82% (n=501) of VLBW infants 
born in the ROI survived to discharge home 
or first birthday, four percent below the VON 
rate (86%, n=52,591; Table 3.1). As in 2014, the 
2017 crude ROI survival rate was statistically 
different from the VON rate (2014, p=0.01; 2017, 
p=0.01; Table 3.2). The 2017 figures represent 
a decrease in the survival rates for ROI infants 
from 84% in 2015 and 2016 to 82% survival in 
2017, similar to values recorded for 2014.
The percentages of those who survived without 
specified morbidities (i.e. the key morbidities of 
severe IVH, chronic lung disease in infants <33 
weeks gestation, NEC, pneumothorax, any late 
infection or cystic PVL) in 2017 was 57% (n=343 
of 605, unknown for 7 infants) in the ROI and 
57% (n=34,919) in VON, a difference which was 
not statistically significant (p=0.879; Table 3.1). 
The ROI survival without specified morbidities 
rate has shown a slight but steady increase 
since 2014 (Table 3.12). 
Table 3.1: Survival of ROI and VON infants, including those with congenital anomalies, 2017. 
Measure
Republic of Ireland VON
Cases N % Cases N % P-value
Survival* 501 611 82 52,591 61,366 86 0.009
Survival without specified morbidities** 343 605 57 34,919 61,261 57 0.879
Note: N represents all babies for whom the variable applies (the denominator). The P-value refers to the significance of the 
value of the difference between the ROI and VON populations.
 * Indicates whether the infant survived to discharge home or first birthday
 **  Denotes severe IVH, chronic lung disease in infants <33 weeks gestation, NEC, pneumothorax,  
any late infection or cystic PVL.
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Table 3.2: Survival of ROI and VON infants, including those with congenital anomalies, 2014 - 2017. 
Characteristic


























52 57 0.02 54 57 0.16 56 57 0.74 57 57 0.88
Note: N represents all babies for whom the variable applies (the denominator). The P-value refers to the significance of the 
value of the difference between the ROI and VON populations.
 * Indicates whether the infant survived to discharge home or first birthday
 **  Denotes severe IVH, chronic lung disease in infants <33 weeks gestation, NEC, pneumothorax,  
any late infection or cystic PVL.
Survival to discharge of VLBW infants by birth 
weight and gestational age is reported in Tables 
3.3 and 3.4 respectively for the years 2014 
through to 2017. In line with previous years, there 
was a general trend of increased survival to 
discharge with increasing birth weight in 2017 
(Table 3.3). In 2017, three (n=23, 13%) infants born 
less than 501g survived, whilst the analogous 
figures for 2016 were six (n=21, 29%), four (n=23, 
17%) for 2015 and two (n=26, 8%) for 2014. 
Survival to discharge increased with advancing 
gestational age in 2017 until 30 weeks gestation, 
above which there was a slight variation away 
from this pattern, consistent with previous years 
(Table 3.4). At 23 weeks gestation, seven infants 
(47% of 15 infants) survived to discharge in 2017, 
whilst ten (37% of 27 infants), nine (30% of 30 
infants) and four (19% of 21 infants) survived in 
2016, 2015 and 2014 respectively. This shows an 
increase in the percentage of survival for this 
gestational age year on year. 
Table 3.3: Birth weight and survival to discharge of ROI infants reported to VON, including those with congenital 
















No. of liveborn  
infants (%)
<501g 2/26 (8%) 4/23 (17%) 6/21 (29%) 3/23 (13%)
501-600g 9/32 (28%) 19/37 (51%) 12/33 (36%) 16/39 (41%)
601-700g 24/36 (67%) 29/45 (64%) 32/51 (63%) 23/33 (70%)
701-800g 27/37 (73%) 26/37 (70%) 35/49 (71%) 29/43 (67%)
801-900g 29/37 (78%) 33/40 (83%) 40/47 (85%) 35/47 (74%)
901-1000g 51/58 (88%) 34/39 (87%) 45/49 (92%) 48/53 (91%)
1001-1100g 47/54 (87%) 54/59 (92%) 51/54 (94%) 55/64 (86%)
1101-1200g 60/64 (94%) 58/64 (91%) 62/67 (93%) 60/64 (94%)
1201-1300g 77/81 (95%) 63/67 (94%) 61/63 (97%) 65/69 (94%)
1301-1400g 67/72 (93%) 84/87 (97%) 62/64 (97%) 74/80 (93%)
>1400g 94/99 (95%) 121/124 (98%) 90/95 (95%) 93/97 (96%)
Total 487/596 (82%) 525/622 (84%) 496/593 (84%) 501/612 (82%)
Note: One infant in 2014 did not have a recorded birth weight and therefore the denominator was 596. 
17
Table 3.4: Gestational age breakdown and survival to discharge of ROI infants reported to VON, including those 
















No. of liveborn  
infants (%)
<22 weeks 0/2 (0%) 0/2 (0%) 0/2 (0%) 0/6 (0%)
22 weeks 0/18 (0%) 0/16 (0%) 0/19 (0%) 0/16 (0%)
23 weeks 4/21 (19%) 9/30 (30%) 10/27 (37%) 7/15 (47%)
24 weeks 18/36 (50%) 22/34 (65%) 25/45 (56%) 21/37 (56%)
25 weeks 25/35 (71%) 33/43 (77%) 39/50 (78%) 27/50 (54%)
26 weeks 28/43 (65%) 30/37 (81%) 34/39 (87%) 31/39 (79%)
27 weeks 54/57 (95%) 40/46 (87%) 47/49 (96%) 60/69 (87%)
28 weeks 75/83 (90%) 82/90 (91%) 77/83 (93%) 83/88 (94%)
29 weeks 89/95 (94%) 94/99 (95%) 80/85 (94%) 74/83 (89%)
30 weeks 68/71 (96%) 65/65 (100%) 62/66 (94%) 84/87 (97%)
31 weeks 44/49 (90%) 64/68 (94%) 49/50 (98%) 52/54 (96%)
32 weeks 36/39 (92%) 35/37 (95%) 34/36 (94%) 28/31 (90%)
>32 weeks 46/48 (96%) 51/55 (93%) 39/42 (93%) 34/37 (92%)
Total 487/597 (82%) 525/622 (84%) 496/593 (84%) 501/612 (82%)
As shown in Table 3.5, the proportion of 
infants surviving discharge without specified 
morbidities increased with advancing gestational 
ages. The percentage of infants surviving 
without specified morbidities has also marginally 
increased over the past four years. None of the 
infants born with 22 or lower gestational age 
survived. However, one infant born at 23 weeks 
gestation survived to discharge without any of 
the specified morbidities in 2017. 
Table 3.5: Survival without specified morbidities1 of infants according to gestational age at birth of ROI infants 
reported to VON, 2014 (N=597); 2015 (N=622); 2016 (N=593); 2017 (N= 612). 
Gestational Age
2014 
No. of survivors 
without morb./ No. of 
liveborn infants (%)
2015 
No. of survivors 
without morb./ No. of 
liveborn infants (%)
2016 
No. of survivors 
without morb./ No. of 
liveborn infants (%)
2017 
No. of survivors 
without morb./ No. of 
liveborn infants (%)
≤ 22 weeks 0/20 (0%) 0/18 (0%) 0/21 (0%) 0/22 (0%)
23 weeks 0/21 (0%) 1/30 (3%) 2/27 (7%) 1/15 (7%)
24-27 weeks 45/169 (27%) 40/160 (25%) 59/183 (32%) 57/190 (30%)
28-31 weeks 193/297 (65%) 213/322 (66%) 202/284 (71%) 226/310 (73%)
≥32 weeks 73/87 (84%) 83/92 (90%) 70/78 (90%) 59/68 (87%)
Total 311/594
2





Note: Figures include infants with congenital anomalies. 1Specified Morbidities include severe IVH, chronic lung disease in 
infants <33 weeks gestation, NEC, pneumothorax, any late infection and/or cystic PVL. 2Data on survival without specified 
morbidities unknown for: 2 infants born at 24-27 weeks gestation and 1 infant born at 28-31 weeks in 2014; 1 infant born at 
24-27 weeks gestation in 2016; 5 infants born at 24-27 weeks gestation and 2 infants born at 28-31 weeks in 2017.
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4. Key Performance Indicators
VON reports on a number of Key 
Performance Indicators (KPIs). This allows 
the ROI to compare its outcomes to VON 
as a whole. It is important for benchmarking 
performance in the ROI in addition to 
identifying areas of strengths and areas 
where continuous improvements could/
should be made. 
The KPIs are listed below and relevant 
definitions are outlined above in the 
Definitions and Terminology section:
1. Mortality
2. Mortality Excluding Early Deaths 
3. Death or Morbidity 
4. CLD
5. Pneumothorax
6. Late Bacterial Infection
7. Coagulase Negative Infection
8. Nosocomial Infection
9. Fungal Infection







For each KPI, the number and percentage of 
ROI infants that experienced the outcome 
in 2017 is reported and illustrated in the 
following charts alongside the equivalent 
figures for all infants recorded in the VON 
database. The reporting of the KPIs in 
numbers and percentages for ROI and VON 
infants is provided for descriptive purposes. 
Observed differences in KPIs may be related 
to the medical care provided but may also 
be due to differences between the ROI and 
VON infant populations. Robust comparison 
of KPIs between the ROI and VON requires 
that pertinent differences between the infant 
populations are taken into account. This is 
done through the calculation of standardised 
mortality/morbidity Ratios (SMRs).
Standard Mortality/Morbidity Ratios 
(SMRs)
Based on all VON data for infants with birth 
weights 501-1500g, our VON colleagues use 
multivariable logistic regression models for 
each KPI to quantify the risk of the outcome 
associated with each of the following infant 
characteristics: gestational age, SGA, multiple 
gestation, Apgar score at 1 min, gender, 
vaginal birth, location (inborn or outborn) 
and birth defect severity. Coefficients from 
these regression models were provided to the 
NPEC for use in the calculation of SMRs for 
each KPI.
SMRs were calculated for ROI babies with 
birth weights 501-1500g and with complete 
data for the KPI in question and the infant 
characteristics used in the regression models.
For each KPI, the coefficients were applied 
to the data of these eligible ROI infants 
to estimate the risk of the outcome for 
each infant. Summing these individual risk 
estimates gives the total number of infants 
that would be expected to experience the 
outcome, i.e. the expected number taking into 
account the risk profile of the ROI infants.
To obtain the SMR for each KPI, the 
number of eligible ROI infants that actually 
experienced the outcome, i.e. the observed 
number of cases, was divided by the 
expected number of cases (SMR = Observed/
Expected).
SMR values equal or close to one indicate 
that there is little or no difference between 
the observed and expected number of infants 
that experienced the outcome, i.e. the number 
observed was to be expected given the risk 
profile of the ROI infant population. SMRs 
greater than one indicate that more infants 
experienced the outcome than expected 
given the risk profile of the ROI infants. SMRs 
less than one indicate that fewer cases were 
observed among ROI infants than expected.
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A 95% confidence interval was calculated 
for each SMR in order to facilitate making 
inferences about whether the SMRs indicated 
if the difference between observed and 
expected was statistically significant. If the 
95% confidence interval did not include 
the value one, it may be inferred that the 
difference between the numbers of observed 
and expected cases was statistically 
significant, i.e. there were more or fewer cases 
among the ROI infants than expected given 
their risk profile.
For each KPI, the absolute difference between 
the observed and expected number of cases 
is reported and the 95% confidence interval 
for this difference is also reported in order 
to provide statements in terms of the actual 
number of infants affected.
SMRs for Key Performance indicators in 2017
Table 4.1 displays Standardised Mortality/
Morbidity Ratios (SMR = Observed/Expected), 
the lower and upper bounds of its 95% 
confidence interval, the difference between 
the Observed and Expected number of cases 
and the lower and upper bound of the 95% 
confidence interval for this difference.
Of all the KPIs measured, Pneumothorax 
recorded the highest SMR (1.69; CI 1.29, 2.10). 
Sixteen more infants experienced this outcome 
in ROI than would have been expected 
considering their risk profile. 
Additionally, the SMR data shows that ROI 
infants were statistically less likely to be 
diagnosed with retinopathy of prematurity 
(SMR 0.72; CI 0.54, 0.89).
Table 4.1: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators, Republic of 
Ireland, 2017.
Outcome O E SMR (95% CI) O-E (95% CI)
Mortality 88 74 1.19 (0.96, 1.42) 14 (-3, 31)
Mortality excluding early death 61 51 1.20 (0.93, 1.48) 10 (-4, 24)
Death or Morbidity 247 244 1.01 (0.89, 1.14) 3 (-27, 34)
Chronic Lung Disease 115 103 1.12 (0.93, 1.31) 12 (-8, 32)
Pneumothorax* 40 24 1.69 (1.29, 2.1) 16 (7, 26)
Late Bacterial Infection 39 44 0.89 (0.59, 1.18) -5 (-18, 8)
Coagulase Negative Infection 33 28 1.16 (0.8, 1.53) 5 (-6, 15)
Nosocomial Infection 66 63 1.04 (0.8, 1.29) 3 (-13, 18)
Fungal Infection 4 5 0.84 (0.0, 1.74) -1 (-5, 4)
Any Late Infection 67 65 1.03 (0.78, 1.27) 2 (-14, 17)
Intraventricular Haemorrhage 129 132 0.98 (0.81, 1.15) -3 (-25, 20)
Severe Intraventricular Haemorrhage 35 39 0.90 (0.59, 1.22) -4 (-16, 8)
Retinopathy of Prematurity* 85 119 0.72 (0.54, 0.89) -34 (-55, -12)
Severe Retinopathy of Prematurity 20 20 0.98 (0.55, 1.42) 0 (-9, 8)
Cystic Periventricular Leukomalacia 10 15 0.66 (0.15, 1.16) -5 (-13, 2)
Necrotising Enterocolitis 35 29 1.22 (0.86, 1.59) 6 (-4, 17)
“O” refers to the number of observed cases with the outcome and “E” to the expected number with the outcome of ROI 
infants with birth weights 501-1500g. 95% confidence intervals (CIs) are provided for the SMR and the difference in observed 
and expected cases. *Indicates a statistically significant difference.
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Analyses of the three-year period, 2014-
2016, showed that there was a statistically 
significant 17% elevated risk of mortality 
among ROI infants after adjusting for the risk 
profile of the population (SMR 1.17; 95% CI: 
1.05, 1.29). Annually, there was an average of 14 
more deaths than expected during this time.
(2) Though not statistically significant when 
considered in isolation, the mortality risk in 
2017 was consistent with that observed in the 
previous three years (Table 4.3, pg. 24). After 
adjusting for the risk profile the SMR was 19% 
higher than expected (SMR 1.19; CI 0.96, 1.42) 
and the excess number of deaths was 14 (Table 
4.1). The findings are similar when mortality 
excluding early deaths was considered 
(SMR=1.20; CI 0.93, 1.48). 
Mortality in infants with birth weights  
501-1500g
Amongst ROI infants with birth weights 
501-1500g, there were 88 deaths observed 
whereas the expected number based on the 
risk profile of the infants in the ROI population 
was 74 (Table 4.1). The SMR was 1.19 (95% 
CI: 0.96, 1.42), indicating that the number of 
observed cases was 1.19 times the expected 
number. In absolute numbers there were 14 
more deaths than expected. This was not a 
statistically significant excess in mortality (95% 
CI: -3, 31).
Excluding early deaths, there were 61 observed 
deaths and 51 expected deaths based on the 
risk profile of infants in the ROI (SMR=1.20, 
95% CI: 0.93, 1.48: Table 4.1). Thus, there were 
ten more observed deaths (excluding early 
deaths) than those expected. This difference 
was, however, not statistically significant (95% 
CI -4, 24).
Death or Morbidity in infants with birth 
weights 501-1500g
Amongst ROI infants with birth weights 501-
1500g, there were 247 observed cases of 
death or morbidity, whereas the expected 
number based on the risk profile of the infants 
in the Irish population was 244 (Table 4.1). The 
SMR was 1.01 (95% CI: 0.89, 1.14), indicating 
that the number of observed cases was 
approximately similar to the expected number. 
In absolute numbers there were 3 more 
cases of death or morbidity in the ROI than 
expected, a finding which was not statistically 
significant (95% CI: -27, 34). 
Chronic Lung Disease in infants with birth 
weights 501-1500g
There were 115 observed cases of Chronic 
Lung Disease (CLD) amongst ROI infants with 
birth weights 501-1500g whereas the expected 
number based on the risk profile of infants in 
the Irish population was 103 (Table 4.1). The 
SMR was 1.12 (95% CI0.93, 1.31), indicating that 
the number of observed cases was 1.12 times 
the expected number. In absolute numbers 
there were 12 more cases of CLD than 
expected: this was not a statistically significant 
increase (95% CI: -8, 32).
Pneumothorax in infants with birth weights 
501-1500g
There were 40 observed cases of 
pneumothorax amongst ROI infants with birth 
weights 501-1500g whereas the expected 
number based on the risk profile of the infants 
in the Irish population was 24 (Table 4.1). The 
SMR was 1.69 (95% CI: 1.29, 2.1), indicating that 
the number of observed cases was 1.69 times 
the expected number. In absolute numbers 
there were 16 more cases of pneumothorax 
(95% CI: 7, 26) than expected, a statistically 
significant difference. 
Infections: late bacterial infection, coagulase 
negative infection, nosocomial infection, 
fungal infection and any late infection 
Figure 4.1 illustrates the proportions of 
infections in ROI and VON infants. There 
was no statistically significant difference in 
the rates of any infection between the two 
populations in 2017 (late bacterial infection: 
p=0.07; coagulase negative infection: p=0.15; 
nosocomial infection: p=0.22; fungal infection: 
p=0.96; any late infection: p=0.30). 
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Figure 4.1: Distribution of infections in ROI and VON infants, 2017. 
Late Bacterial Infection in infants with birth 
weights 501-1500g
Amongst ROI infants with birth weights 501-
1500g, there were 39 observed cases of late 
bacterial infection compared to an expected 
number of 44 cases (Table 4.1). Thus, the 
observed number was 0.89 times the expected 
number (SMR=0.89, 95% CI: 0.59, 1.18). In absolute 
numbers there were five fewer cases of late 
bacterial infection than expected, although this 
was not statistically significant (95% CI: -18, 8).
Coagulase negative infection in infants with 
birth weights 501-1500g
Adjusting for the risk profile of ROI infants born 
weighing 501-1500g, there were 33 observed 
cases of coagulase negative infection compared 
to an expected number of 28 cases (Table 4.1). 
Thus, the observed number was 1.16 times the 
expected number (SMR=1.16, 95% CI: 0.8, 1.53). 
In absolute numbers there were 5 more cases 
of coagulase negative infection than expected, 
though this was not a statistically significant 
excess (95% CI: -6, 15).
Nosocomial infection in infants with birth 
weights 501-1500g
There were 66 observed cases of nosocomial 
infection amongst ROI infants with birth weights 
501-1500g, whereas the expected number based 
on the risk profile of the infants was 63 cases 
(Table 4.1). Thus, there were 1.04 times more 
cases observed than expected (SMR=1.04, 95% 
CI: 0.8, 1.29). In absolute numbers this equated to 
an excess of 3 cases, which was not a statistically 
significant difference (95% CI: -13, 18).
Fungal Infection in infants with birth weights 
501-1500g
The four observed cases of fungal infection were 
amongst the infants born weighing 501-1500g. 
Based on the risk profile of ROI infants, there 
was an expected number of five cases (Table 4.1) 
which is one more case than those observed. 
However, this one case of fungal infection lower 
than expected did not constitute a statistically 
significant reduction in fungal infection cases 
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22 VERY LOW BIRTH WEIGHT INFANTS IN THE REPUBLIC OF IRELAND ANNUAL REPORT 2017
Any late Infection in infants with birth 
weights 501-1500g
Considering ROI infants born weighing 
501-1500g for whom risk adjustment was 
performed, there were 67 observed cases with 
any late infection compared to an expected 
number of 65 cases (Table 4.1). Thus, the 
observed number equated to 1.03 times 
the expected number (SMR=1.03, 95% CI: 
0.78, 1.27) and the excess of 2 cases was not 
statistically significant (95% CI: -14, 17).
IVH and severe IVH in infants with birth 
weights 501-1500g
IVH was observed in 129 ROI infants weighing 
501-1500g at birth whereas the number of 
cases expected based on the infants’ risk 
profile was 132 (SMR=0.98, 95% CI: 0.81, 1.15; 
Table 4.1). In absolute numbers, there were 
3 fewer cases than expected, which was not 
statistically significant (95% CI: -25, 20). 
For severe IVH, there were 35 observed 
cases compared to an expected number of 
39 cases (SMR=0.90, 95% CI: 0.59, 1.22): this 
difference of 4 cases less than expected was 
not statistically significant (95% CI: -16, 8; 
Table 4.1). 
ROP in infants with birth weights 501-1500g
Considering ROI infants born weighing 
501-1500g for whom risk adjustment was 
performed, there were 85 observed cases of 
ROP compared to an expected number of 119 
cases (Table 4.1). Thus, the observed number 
equated to 72% of the expected number, 
which constituted a statistically significant 
difference (SMR=0.72, 95% CI: 0.54, 0.89). In 
absolute numbers, there were 34 fewer cases 
of ROP than expected, which was a statistically 
significant reduction (95% CI: -55, -12).
With regard to severe ROP, there were 20 
observed cases which was also the number 
of expected cases based on the risk profile 
of infants in the ROI population (SMR=0.98, 
95% CI: 0.55, 1.42). The equal number cases 
of severe ROP cases were, however, not 
statistically significant (95% CI: -9, 8; Table 4.1).
Cystic PVL in infants with birth weights  
501-1500g
Considering ROI infants with 501-1500g birth 
weights, there were 10 observed cases of 
cystic PVL whereas the number expected 
based on their risk profile was 15 (Table 4.1). 
Thus, the observed number was 0.66 time 
lower than the expected (SMR=0.66, 95% 
CI: 0.15, 1.16). In absolute numbers the five 
fewer cases observed did not represent a 
statistically significant difference from the 
expected number (95% CI: -13, 2).
NEC (Necrotising Enterocolitis) in infants 
with birth weights 501-1500g
Amongst the ROI infants born weighing 
501-1500g there were 35 observed cases of 
NEC and an expected number of 29 cases 
(SMR=1.22, 95% CI: 0.86, 1.59; Table 4.1). This 
was not a statistically significant finding (95% 
CI: -4, 17).
Key Performance Indicators and 
Gestational Age
The proportion and number of infants 
recording each of the KPIs measured 
according to their gestational age is outlined 
in table 4.2. As there were no infants born at 
22 weeks who survived and only one infant 
born at 23 weeks survived to discharge, this 
analysis was carried out for infants born at a 
gestational age ≥24 weeks.
A statistically significant decrease in all 
KPIs was observed with higher gestational 
ages. This denotes a lower percentage of 
mortality, morbidity and specific outcomes 
(as measured in the KPIs) in infants born with 
higher gestational ages.
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Table 4.2: Distribution of each Key Performance Indicator according to gestational age categories of VLBW 
infants with birth weights 501-1500g born in the ROI, 2017.
Outcomes 24-27 weeks 28-31 weeks ≥32 weeks Total
Mortality 55 (28.4%) 19 (6.1%) 6 (8.8%) 80 (13.9%)
Mortality excluding early death 44 (24.6%) 12 (3.9%) 2 (3.1%) 58 (10.6%)
Death or Morbidity 133 (70%) 84 (27.1%) 9 (13.2%) 226 (39.8%)
Chronic Lung Disease 66 (51.2%) 37 (12.9%) 5 (8.1%) 108 (22.6%)
Pneumothorax 19 (10.1%) 15 (4.9%) 0 (0%) 34 (6.1%)
Late Bacterial Infection 31 (17.9%) 9 (3%) 0 (0%) 40 (7.5%)
Coagulase Negative Infection 14 (8.1%) 11 (3.7%) 2 (3.1%) 27 (5.1%)
Nosocomial Infection 40 (23.1%) 19 (6.4%) 2 (3.1%) 61 (11.4%)
Fungal Infection 5 (2.9%) 0 (0%) 0 (0%) 5 (0.9%)
Any Late Infection 41 (23.7%) 19 (6.4%) 2 (3.1%) 62 (11.6%)
Intraventricular Haemorrhage 68 (38.6%) 43 (14.6%) 3 (6%) 114 (21.9%)
Severe Intraventricular Haemorrhage 21 (11.9%) 6 (2%) 0 (0%) 27 (5.2%)
Retinopathy of Prematurity 54 (42.2%) 20 (7.4%) 2 (4.9%) 76 (17.4%)
Severe Retinopathy of Prematurity 14 (10.9%) 2 (0.7%) 1 (2.4%) 17 (3.9%)
Cystic Periventricular Leukomalacia 5 (2.8%) 5 (1.7%) 0 (0%) 10 (1.9%)
Necrotising Enterocolitis 30 (15.9%) 3 (1%) 1 (1.6%) 34 (6.1%)
Note: Association between outcomes (KPIs) and gestational age was significant at P-value <0.01. 
Relative Risks (RRs)
SMRs for each KPI have been calculated for 
ROI infants with birth weights 501-1500g for 
four years, 2014 through to 2017: these SMRs 
facilitate an assessment of relative risks (RRs) i.e. 
whether the risk of a KPI changed from 2014 to 
2017 or from 2016 to 2017. RRs were obtained by 
comparing the SMRs calculated for one year to 
those calculated for the preceding year using the 
methods described by Breslow and Day (1987).(3) 
For each KPI, this involved calculating the relative 
risk by dividing the SMR for 2017 by the SMR for 
2014 (RR=SMR 2017 / SMR 2014) or by dividing 
the SMR for 2017 by the SMR for 2016 (RR=SMR 
2017 / SMR 2016).
A 95% confidence interval was calculated for 
each relative risk in order to facilitate making 
inferences about whether the change in the risk of 
the KPI from one year to the next was statistically 
significant. If the 95% confidence interval did not 
include the value one, it may be inferred that the 
change in the risk of the KPI from 2014 to 2017 
or from 2016 to 2017 was statistically significant, 
i.e. the risk of the KPI among the ROI infants was 
higher or lower in 2017 than it was in 2014 or in 
2017 than it was in 2016.
This approach has the advantage of adjusting for 
the risk profile of the ROI infants in each year and 
any change in this risk profile from one year to 
the next.
For each KPI, Table 4.3 displays the SMR and its 
95% confidence interval for the years 2014 - 2017 
and the relative risk comparing 2014 to 2017 and 
2016 to 2017 and its 95% confidence interval.
Overall there has not been any change in the 
relative risk of the studied outcomes between 
2014 and 2017. While not significant, there was, 
however, evidence of an improvement in relation 
to the rates of Coagulase Negative Infection. 
In 2014, there was an 84% elevated risk of this 
outcome in VLBW infants in ROI in 2014 and this 
has reduced to 16% in 2017 (SMR 0.63; CI 0.39, 
1.01).
The risk of ROP among VLBW infants in ROI 
continues to be lower than expected, albeit by 
a smaller percentage in 2017 (SMR 0.72; CI 0.99, 
1.99) than in 2014 (SMR 0.51; CI 0.33, 0.70).












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5. Survival according to designated category of neonatal unit
There are 19 neonatal centres in the ROI. These 
are classified as tertiary, regional or peripheral 
neonatal centre based on the number of 
births per annum in the affiliated obstetric 
centre and the level of neonatal consultant 
cover in the neonatal centre. There are four 
designated tertiary neonatal centres, four 
designated regional neonatal centres and 
eleven designated peripheral neonatal centres 
(Table 5.1). Each of the tertiary centres deliver 
more than 8,000 births per annum and all 
provide 24 hour consultant neonatology cover. 
The regional centres have dedicated neonatal 
intensive care units (NICUs) in their centres but 
do not have 24-hour consultant neonatology 
cover. In 2017, one of these four centres 
delivered between 4,000-5,000 births per 
annum; two centres delivered between 3,000-
4,000 births per annum (one centre was just 
over the 3,000 mark having had 3,001 births); 
and the fourth centre delivered less than 2,000 
births per annum when births weighing 500g or 
more are counted (Table 5.1). Peripheral centres 
do not have dedicated NICUs nor do they have 
dedicated consultant neonatology cover but 
they do have designated areas for newborn 
infants namely Special Care Baby Units 
(SCBUs). In 2017 as in the previous years, all but 
one peripheral centre delivered less than 2,000 
births per annum and that one centre delivered 
between 2,000-3,000 births per annum. 
Table 5.1: Number of live births and stillbirths weighing greater than or equal to 500g in maternity 
centres in 2016. 
Hospital Number of births 
Designated Tertiary Neonatal Centres
National Maternity Hospital > 8,000
Coombe Women & Infants University Hospital > 8,000
Rotunda Hospital > 8,000
Cork University Maternity Hospital > 8,000
Designated Regional Neonatal Centres
University Maternity Hospital Limerick 4,000-5,000
Our Lady of Lourdes Hospital Drogheda 3,000-4,000
Galway University Hospital 3,000-4,000
University Hospital Waterford < 2,000
Designated Peripheral Neonatal Centres
Midland Regional Hospital Mullingar 2,000-3,000
Portiuncula Hospital Ballinasloe < 2,000
Wexford General Hospital < 2,000
Midland Regional Hospital Portlaoise < 2,000
St Luke’s Hospital Kilkenny < 2,000
Cavan General Hospital < 2,000
Mayo University Hospital < 2,000
Letterkenny University Hospital < 2,000
University Hospital Kerry < 2,000
Sligo University Hospital < 2,000
South Tipperary General Hospital < 2,000
Source: Annual Clinical Reports of hospitals and hospital groups; and personal communication with individual.
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All the 612 VLBW infants reported to VON in 
2017, had birth location data suitable for analysis 
of survival outcome based on the designated 
category of neonatal centre in which they were 
born (i.e. tertiary, regional or peripheral). 
In 2017, 433 infants (71%) were born in one of 
the four tertiary neonatal centres, 112 (18%) were 
born in one of the four regional neonatal centres 
and the remaining 67 infants (11%) were born in 
one of eleven peripheral centres (Table 5.2). This 
compares to proportions of 73% (n=121), 20% 
(n=115) and 7% (n=41) born in tertiary, regional 
and peripheral centres in 2016.(4) 
Resuscitation in the delivery room (defined as 
the administration of positive pressure breaths 
via a face mask and/or an endotracheal tube) 
was provided to a total of 417 (68%) infants in 
2017 (Table 5.2) compared to 72% of infants in 
2016. Overall, 73% of those born in a tertiary 
centre, 60% of those born in a regional centre 
and 51% of those born in a peripheral centre 
were resuscitated in 2017 (Table 5.2). This 
compares to figures of 78%, 53% and 66% 
respectively for the previous year.(4) 











Liveborn infants 433 (71%) 112 (18.3%) 67 (11%) 612
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Of the 417 infants who received resuscitation 
in the delivery room, six of these infants died 
in the delivery room and 383 survived to 
admission to a NICU/SCBU (Figure 5.1). The 
gestational age category of infants resuscitated 
according to the category of neonatal centre 
where these infants were born, is shown in table 
5.3. The vast majority of babies resuscitated 
had a gestational age of ≥ 23 weeks at birth. Of 
the 417 infants who received resuscitation, 343 
(82%) survived to discharge (Figure 5.1). The 
remaining 73 (18%) infants died, six of whom 
died in the delivery room. Survival outcome 
was not known for one infant. 
Table 5.3: Number of infants born in each category of neonatal centre who were administrated resuscitation 













born (% of liveborn)
Total
≤ 22 weeks 1/13 (8%) 1/3 (33%) 0/6 (0%) 2/22 (9%)
23 weeks 11/12 (92%) 1/1 (100%) 1/2 (50%) 13/15 (87%)
24-27 weeks 141/155 (91%) 22/27 (81%) 11/13 (85%) 174/195 (89%)
28-31 weeks 149/213 (70%) 38/64 (59%) 21/35 (60%) 208/312 (67%)
≥ 32 weeks 14/40 (35%) 5/17 (29%) 1/11 (9%) 20/68 (29%)
Total 316/433 (73%) 67/112 (60%) 34/67 (51%) 417/612 (68%)
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Admission to NICU/SCBU was recorded for 
575 infants, of which 413 (95%) were born at 
tertiary centres, 107 (96%) at regional centres 
and 55 (82%) at peripheral centres (Table 
5.2). These numbers included infants who 
were transferred out of the birth hospital 
and to another neonatal and/or paediatric 
centre within 48 hours of birth. A total of 28 
(5%) of the 612 infants were transferred and 
the majority of these (n=19; 68% of the total 
infants transferred) were born in peripheral 
centres. One infant from a tertiary centre was 
transferred out within 48 hours of birth to a 
paediatric hospital, and the other three were 
transferred to other general hospitals in Ireland. 
The five infants from regional centres and the 
19 infants from peripheral centres were all 
transferred out to tertiary neonatal centres. 
Table 5.4 outlines the gestational age category 
of the infants born in each of the three 
categories of neonatal centres with reference 
to those infants who required transfer. As 
shown in the table, the majority of transfers 
from peripheral centres related to infants born 
between 24-27 and 28-31 weeks gestation 
whereas the four transfers that occurred 
from tertiary centres related to infants with a 
gestation birth between 28-31 weeks. 
Table 5.4: Number of infants born in each category of neonatal centre, and number transferred within  
48 hours, according to gestational age, 2017, n=612.
Gestational Age
TERTIARY 
No. transferred  
within 48 hours/  
No. born (%)
REGIONAL 
No. transferred  
within 48 hours/  
No. born (%)
PERIPHERAL 
No. transferred  
within 48 hours/  
No. born (%)
≤ 22 weeks 0/13 (0%) 0/3 (0%) 0/6 (0%)
23 weeks 0/12 (0%) 1/1 (100%) 1/2 (50%)
24-27 weeks 0/155 (0%) 3/27 (11%) 9/13 (69%)
28-31 weeks 4/213 (2%) 1/64 (2%) 9/35 (26%)
≥ 32 weeks 0/40 (0%) 0/17 (0%) 0/11 (0%)
Total 4/433 (1%) 5/112 (4%) 19/67 (28%)
The overall crude survival rate for ROI infants in 2017 was 82% (n=501): the highest rate of 
survival occurred in the regional centres (88%), followed by the tertiary centres at 81% and the 
peripheral centres at 79% (Figure 5.1 and Table 5.2). In 2016, regional centres had a survival rate 
of 86%, and tertiary and peripheral centres had a rate of 83%.(4)












4 Died in DR 4 Died
117 Did Not Receive 
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2 Died in DR 2 Died
45 Did Not Receive 
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0 Died in DR 0 Died
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12 Died in DR 12 Died
349 (81%) survived 
83 (20%) died
99 (88%) survived 
13 (12%) died









Figure 5.1: Flow chart illustrating survival outcomes of all VLBW infants born, according to 
designated category of neonatal centre, 2017, n=612. (*One infant’s outcome not known) 
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Survival of infants born at 22 and 23 
weeks gestation according to category 
of neonatal centre
Overall, 37 infants were born <24 weeks gestation, 
of which 25 (68%) were born in tertiary neonatal 
centres, 4 (11%) in regional centres and the 
remaining eight (22%) in one of the eleven 
peripheral centres. 
Infants born at 22 weeks gestation (or less) in ROI
Of the 22 infants born at 22 weeks (or less) 
gestation in Ireland in 2017, 6 (27%) were born in 
peripheral centres, 3 (14%) in regional centres and 
13 (59%) infants were born in tertiary centres.
Two infants were provided with resuscitation in 
the delivery room (Table 5.5), one infant born in 
a tertiary centre and one infant born in a regional 
centre. Both infants who received resuscitation in 
the delivery room were admitted to NICU although 
they did not survive to discharge. 
The remaining 20 infants born at 22 weeks (or less) 
gestation died in the delivery room, none of these 
infants had an MCA.











Liveborn infants 13 3 6 22
Received resuscitation in the delivery room 1 (7.7%) 1 (33.3%) 0 2 (9.1%)
Admitted to a NICU/SCBU 1 (7.7%) 1 (33.3%) 0 2 (9.1%)
Transferred to another neonatal centre within 
48 hours of birth 
0 0 0 0
Survived to discharge 0 0 0 0
Note: Percentage from the total liveborn infants in each category. 
Table 5.6 outlines the trend in survival and provision of resuscitation to ROI infants born 
at 22 weeks (or less) gestation over the past 4 years. No infant born ≤22 weeks gestation 
survived to discharge since 2014, the inception of this report. 









Liveborn infants 20 18 21 22 
Received resuscitation in the delivery room 1 (5%) 0 1 (5%) 2 (9%)
Admitted to a NICU/SCBU 0 0 1 (5%) 2 (9%)
Survived to discharge 0 0 0 0
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Infants born at 23 weeks gestation (23+0 to 
23+6) in ROI
A total of 15 infants were born in Ireland at 23 
weeks gestation, the vast majority of these 
delivered in tertiary centres (n=12, 80%) (Table 
5.7). Thirteen of these infants (87%) were 
provided with resuscitation in the delivery room, 
including 11 (92%) of the infants born in tertiary 
centres, one (the only) infant born in a regional 
centre and one of the two infants (50%) who 
were born in a peripheral centre. Of these infants 
who received resuscitation in the delivery room, 
all survived to admission to a NICU/SCBU. 
Two of the 15 infants born at 23 weeks gestation 
died in the delivery room.
Of the 13 infants who survived to admission 
to a NICU/SCBU, two infants were transferred 
from their hospital of birth soon after they were 
born (Table 5.7). One was born in a peripheral 
centre and the other in a regional centre and 
both were transferred to one of the four tertiary 
centres. One was transferred on the same day 
of birth and one was transferred on Day 2 (i.e. 
on the day after the infant was born irrespective 
of the time of birth). Both survived to discharge. 
In total, seven infants born at 23 weeks 
gestation in 2017 survived to discharge, of 
which five were born in tertiary centres, one in 
a regional centre and one in a peripheral centre 
(Table 5.7). The overall crude survival rate for 
infants of this gestational age was 47% (n=7/15). 











Liveborn infants 12 1 2 15
Received resuscitation in the delivery room 11 (92%) 1 (100%) 1 (50%) 13/15 (87%)
Admitted to a NICU/SCBU 11 (92%) 1 (100%) 1 (50%) 13/15(87%)
Transferred to another neonatal centre within 
48 hours of birth 
0/12 (0%) 1/1 (100%) 1/2 (50%) 2/15 (13%)
Survived to discharge 5/12 (42%) 1/1 (100%) 1/2 (50%) 7/15 (47%)
Survived to discharge among infants receiving 
resuscitation
5/11 (45%) 1/1 (100%) 1/1 (100%) 7/13 (54%)
Survived to discharge among infants 
admitted to NICU/SCBU
5/11 (45%) 1/1 (100%) 1/1 (100%) 7/13 (54%)
The figures in table 5.8 show an increase, over the past 4 years, in the proportion 
of infants born at 23 weeks gestation who were resuscitated in the delivery room, 
admitted to a NICU/SCBU and who survived to discharge. 









Liveborn infants 21 30 27 15 
Received resuscitation in the delivery room 9 (42%) 22 (73%) 20 (74%) 13 (87%)
Admitted to a NICU/SCBU 5 (24%) 10 (33%) 20 (74%) 13 (87%)
Survived to discharge 4 (19%) 9 (30%) 10 (37%) 7 (47%)
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Table 5.9 displays Standardised Mortality/
Morbidity Ratios (SMR = Observed/Expected) 
for the main KPIs recorded for the infants 
born in ROI between 2014 and 2017, at 23 
weeks gestation. Of the KPIs analysed here, 
Necrotising Enterocolitis (SMR 1.48; CI 0.64, 
2.33) and Mortality (SMR 1.17; CI 0.9, 1.44) 
recorded the highest SMR. Three more infants 
experienced Necrotising Enterocolitis in ROI 
than would have been expected considering 
their risk profile. Similarly, for mortality, there 
were nine more infants who died than would 
have been expected. There were two infants 
less than expected in ROI who developed Cystic 
Periventricular Leukomalacia. 
Table 5.9: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators within 
infants born with 23 weeks gestation in ROI, 2014-2017.
Outcome O E SMR (95% CI) O-E (95% CI)
Mortality 61 52 1.17 (0.9, 1.44) 9 (-5, 23)
Death or Morbidity 17 17 1.01 (0.54, 1.49) 0 (-8, 8)
Chronic Lung Disease 20 18 1.09 (0.64, 1.55) 2 (-7, 10)
Pneumothorax 6 6 1.05 (0.23, 1.87) 0 (-4, 5)
Any Late Infection 17 17 1.01 (0.54, 1.49) 0 (-8, 8)
Severe Intraventricular Haemorrhage 18 16 1.13 (0.64, 1.62) 2 (-6, 10)
Cystic Periventricular Leukomalacia 1 3 0.34 (-0.8, 1.47) -2 (-5, 1)
Necrotising Enterocolitis 8 5 1.48 (0.64, 2.33) 3 (-2, 7)
Outcomes of infants born at 24-
27 weeks gestation according to 
category of neonatal centre
The current Model of Care for Neonatal Services 
in Ireland recommends that infants born 
before reaching a gestational age of 28 weeks 
should ideally be delivered at one of the four 
tertiary neonatal centres.(5) Overall, there were 
195 infants born at 24-27 weeks gestation of 
whom 155 (80%) were born in tertiary neonatal 
centres, 27 (14%) in regional centres and 13 (7%) 
in one of the peripheral centres (Table 5.10; 
Figure 5.2).
Of these 195 infants, 174 (89%) received 
resuscitation in the delivery room, including 141 
(92%) of the infants born in tertiary centres, 22 
(81%) of those born in regional centres and 11 
(85%) of the infants born in peripheral centres 
(Table 5.10). Three infants who were offered 
resuscitation in the delivery room died in the 
delivery room. Two of these deaths occurred 
in tertiary centres and one in a regional centre 
(Figure 5.2). These infants were born at 25, 26 
and 27 weeks gestation respectively and one 
had an MCA.
Twenty one infants did not receive resuscitation 
in the delivery room, 14 of these were born in 
tertiary centres, five in regional centres and two 
in peripheral centres. Three died in the delivery 
room (one case in a tertiary unit and two in 
peripheral centres) and one if these infants had 
an MCA. Of the 18 remaining cases, all of whom 
were admitted to a NICU/SCBU, 16 survived 
to discharge (Table 5.10; Figure 5.2). The two 
infants who did not survive were born in tertiary 
units at 24 and 25 weeks gestation and one had 
an MCA. 
In total, six (3%) infants born at 24-27 weeks 
gestation died in the delivery room, 3 (50%) of 
whom had received resuscitation. 
A total of 189 (97%) infants born at 24-27 
weeks gestation survived to admission to a 
NICU/SCBU. Of these 189 infants, 171 (90%) 
had received resuscitation in the delivery room 
but the remaining 18 infants did not receive 
resuscitation in the delivery room. One of these 
infants were born at 24 weeks, three at 25 
weeks, five at 26 weeks and the final nine at 27 
weeks. 
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Twelve of the 189 infants admitted to NICU (6% 
of those liveborn at 24-27 weeks gestation, 
n=195) were transferred from their hospital of 
birth within 48 hours of birth (Table 5.10). Nine 
of these infants were born in peripheral centres, 
and three in a regional centre (Figure 5.2). All 
were transferred to tertiary neonatal centres 
within 48 hours of birth and 11 of the 12 infants 
survived to discharge.
In total, 139 (72%) infants born at 24-27 weeks 
gestation survived to discharge. The crude 
survival rate was 70% (n=108) for those born 
in tertiary centres, 81% (n=22) for those born in 
regional centres and 69% (n=9) for those born 
in peripheral centres (Table 5.11). 











Liveborn infants 155 27 13 195
Received resuscitation in the delivery room 141 (92%) 22 (81%) 11 (85%) 174/195 (89%)
Admitted to a NICU/SCBU 152 (99%) 26 (96%) 11 (85%) 189/195 (97%)
Transferred to another neonatal centre 
within 48 hours of birth 
0/155 (0%) 3/27 (11%) 9/13 (69%) 12/195 (6%)
Survived to discharge 108/154* (70%) 22/27 (81%) 9/13 (69%) 139/194* (72%)
Survived to discharge among infants 
receiving resuscitation
97/141* (69%) 17/22 (77%) 9/11 (82%) 123/174* (71%)
Survived to discharge among infants 
admitted to NICU/SCBU
108/151* (71%) 22/26 (85%) 8/11 (73%) 138/188* (73%)
* Survival outcome unknown for one infant. This infant was born in a tertiary neonatal centre and require resuscitation at birth. 
The Standardised Mortality/Morbidity Ratios 
(SMR = Observed/Expected) for the main 
KPIs recorded for the infants born in ROI 
between 2014 and 2017, at 24-27 weeks 
gestation are shown in Table 5.11. Of the KPIs 
analysed, the highest SMRs were recorded for 
Necrotising Enterocolitis (SMR 1.87 CI 1.58, 2.15), 
Pneumothorax (SMR 1.31; CI 1, 1.61) and Any Late 
Infection (SMR 1.30; CI 1.12, 1.47). Forty one more 
infants experienced Necrotising Enterocolitis 
in ROI than would have been expected 
considering their risk profile. Similarly, for any 
late infection, there were 36 more infants with 
this morbidity than would have been expected. 
There were ten infants less than expected 
in ROI who developed Cystic Periventricular 
Leukomalacia. 
Table 5.11: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators within 
infants born with 24-27 weeks gestation in ROI, 2014-2017.
Outcome O E SMR (95% CI) O-E (95% CI)
Mortality 168 139 1.20 (1.04, 1.37) 28.5 (5, 52)
Death or Morbidity 480 457 1.05 (0.96, 1.14) 23.4 (-19, 65)
Chronic Lung Disease 232 208 1.11 (0.98, 1.25) 23.6 (-5, 52)
Pneumothorax 54 41 1.31 (1, 1.61) 12.7 (0, 25)
Any Late Infection 157 121 1.30 (1.12, 1.47) 35.8 (14, 57)
Severe Intraventricular Haemorrhage 83 70 1.19 (0.95, 1.42) 13.0 (-3, 29)
Cystic Periventricular Leukomalacia 12 23 0.53 (0.12, 0.94) -10.6 (-20, -1)
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14 Not Offered 
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0 Died in DR 0 Died
2 Not Offered 
Resuscitation
0 Admitted to Birth 
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Hours
2 Died in DR 2 Died
108 (70%) Survived* 
46 (30%) Died
22 (81%) Survived 
5 (19%) Died









*Survival outcome unknown for one infant. 
Figure 5.2: Flow chart illustrating survival outcomes of VLBW born at 24–27 weeks gestation 
according to designated category of neonatal centre, 2017, n=195. 
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Outcomes of infants born at 28-
31 weeks gestation according to 
category of neonatal centre
Overall, there were 312 infants born at 28-31 
weeks gestation of which, 213 (68%) were born 
in tertiary neonatal centres, 64 (21%) in regional 
centres and 35 (11%) in peripheral centres (Table 
5.11; Figure 5.3). 
Of these 312 infants, 208 (67%) received 
resuscitation in the delivery room, which 
included 149 (70%) infants born in tertiary 
centres, 38 (59%) infants born in regional 
centres and 21 (60%) infants born in peripheral 
centres. Three of these infants did not survive 
to admission to a NICU/SCBU, two were born in 
tertiary centres and one was born in a regional 
centre. Two of these infants had an MCA. 
A total of 104 infants did not receive 
resuscitation in the delivery room (64 born in 
tertiary centres, 26 born in regional centres and 
14 born in peripheral centres) (Figure 5.3). Of 
these infants, 101 were subsequently admitted 
to a NICU/SCBU and 98 survived to discharge. 
Two of the 104 infants died in the delivery room 
(both born in peripheral centres), one of whom 
had an MCA. 
A total of five (2%) of the infants born at 28-
31 weeks gestation died in the delivery room, 
3 (60%) of whom had received resuscitation 
(Figure 5.3).
Overall, 307 (98%) infants born at 27-29 weeks 
gestation were admitted to a NICU/SCBU 
including 14 (5% of the total 312 born) infants 
who were subsequently transferred within 48 
hours. Four of these where transferred from 
peripheral centres, one from a regional centre 
and nine from a tertiary centre. Of the 14 infants 
who were transferred, one did not survive 
(Figure 5.3). 
A total of 293 (94%) infants born at 27-29 
weeks gestation survived to discharge: 199 
(93%) of those born in tertiary centres, 61 (95%) 
of those born in regional centres and 33 (94%) 
of those born in peripheral centres (Table 5.12). 











Liveborn infants 213 64 35 312
Received resuscitation in the delivery room 149 (70%) 38 (59%) 21 (60%) 208/312 (67%)
Admitted to a NICU/SCBU 211 (99%) 63 (98%) 33 (94%) 307/312 (98%)
Transferred to another neonatal centre 
within 48 hours of birth 
4/213 (2%) 1/64 (2%) 9/35 (26%) 14/312 (5%)
Survived to discharge 199/213 (93%) 61/64 (95%) 33/35 (94%) 293/312 (94%)
Survived to discharge among infants 
receiving resuscitation
138/149 (93%) 35/38 (92%) 21/21 (100%) 194/208 (93%)
Survived to discharge among infants 
admitted to NICU/SCBU
199/211 (94%) 61/63 (97%) 33/33 (100%) 293/307 (95%)
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Figure 5.3: Flow chart illustrating survival outcomes of VLBW born at 28-31 weeks gestation 
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Outcomes of infants born ≥32 weeks 
gestation according to category of 
neonatal centre
There were 68 infants born at ≥32 weeks 
gestation in 2017, 40 (59%) of these were born 
in tertiary neonatal centres, 17 (25%) in regional 
neonatal centres and 11 (16%) in one of the 
peripheral centres (Table 5.13). 
A total of 20 (29%) infants required resuscitation 
in the delivery room, including 14 (35%) infants 
born in tertiary centres, 5 (29%) infants born 
in regional centres and 1 (9%) infant born in a 
peripheral centre. All survived to admission to a 
NICU/SCBU and only one died before discharge 
(an infant born in a regional unit). There were no 
babies transferred to another neonatal centre 
within 48 hours of birth. 
Table 5.13: Survival of ROI Infants born at or greater than 32 weeks gestation by category of neonatal 











Liveborn infants 40 17 11 68
Received resuscitation in the delivery room 14 (35%) 5 (29%) 1 (9%) 20/68 (29%)
Admitted to a NICU/SCBU 38 (95%) 16 (94%) 10 (91%) 64/68 (94%)
Transferred to another neonatal centre 
within 48 hours of birth 
0/40 (0%) 0/17 (0%) 0/11 (0%) 0/68 (0%)
Survived to discharge 37/40 (93%) 15/17 (88%) 10/11 (91%) 62/68 (91%)
Survived to discharge among infants 
receiving resuscitation
14/14 (100%) 4/5 (80%) 0/1 (0%) 18/20 (90%)
Survived to discharge among infants 
admitted to NICU/SCBU
37/38 (97%) 15/16 (94%) 10/10 (100%) 62/64 (97%)
The other 48 infants born at ≥32 weeks 
gestation did not receive resuscitation in the 
delivery room (26 born in tertiary centres, 
12 born in regional centres and 10 born in 
peripheral centres). Four of these infants died 
in the delivery room (two in tertiary centres and 
one in a regional and peripheral centre) and 
all of these infants had an MCA. The remaining 
44 infants who did not receive resuscitation 
were admitted to a NICU/SCBU and all but 
one survived to discharge. Five of these infants 
were born with MCA, all of them survived to 
discharge. 
Overall, 64 (94%) infants ≥32 weeks gestation 
were admitted to a NICU/SCBU and all but two 
of these survived to discharge (two infants 
died: one born in a tertiary and one from a 
regional centre) (Table 5.13). 
A total of 62 (95%) infants born at ≥32 weeks 
gestation survived to discharge: 37 (93%) of 
those born in tertiary centres, 15 (88%) of those 
born in regional centres and 10 (91%) of those 
born in peripheral centres (Table 5.13). 
Summary survival outcomes of infants 
according to category of neonatal centre
Table 5.14 summarises the survival outcome 
of infants in the different gestational age 
categories according to birth location/category 
of neonatal centre. As rates are based on small 
numbers, particularly at the lower gestational 
ages, firm conclusions cannot be drawn from a 
single year of data. 
At lower gestational ages, the values are too 
small for comparisons to be established. The 
proportion of infants who survived is similar 
across the different categories of neonatal 
centre at 24-27 weeks , 28-31 weeks and ≥32 
weeks gestation.
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Table 5.14: Survival rates for gestational age categories of VLBW infants born in the ROI according to 










ROI Total VON Total
≤ 22 weeks 0 (0%) 0 (0%) 0 (0%) 0 (0%) 165 (11%)
23 weeks 5 (42%) 1 (100%) 1 (50%) 7 (47%) 1209 (44%)
24-27 weeks 108 (70%) 22 (81%) 9 (69%) 139 (71%) 15829 (80%)
28-31 weeks 199 (93%) 61 (95%) 33 (94%) 293 (94%) 26661 (95%)
≥32 weeks 37 (93%) 15 (88%) 10 (91%) 62 (91%) 8742 (95%)
Total 349 (81%) 99 (88%) 53 (79%) 501 (82%) 52605 (85%)
Note: Percentage based on the total number of liveborn infants in each category. 
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6. Mortality and Mortality Excluding Early Death 
In 2017, 18% (n=110) of VLBW babies born in 
the ROI died, 4% higher than the proportion 
of VON infants who died (14%, n=8,775; Table 
6.1). Over half of these ROI infants died either 
in the Delivery Room (6%, n=37) or within 
12 hours of admission to the NICU (1%, n=8; 
Figure 6.1). After excluding early deaths, a 
further 9% (n=65) of ROI infants died. When 
early deaths are excluded, 10% (n=6,041) 
of VON VLBW infants died. This pattern of 
mortality in both the ROI and in VON is similar 
to that observed in previous years.(4, 6, 7)















Died in DR Died within 12 Hours Mortality Excl. Early Deaths Total Mortality
%
Republic of Ireland VON
Table 6.1: Mortality amongst Republic of Ireland and VON infants, 2017. The P-value refers to the 
significance of the value of the difference between the ROI and VON populations.
Republic of Ireland VON
Cases (n) N % N % P-value
Died in DR 37 612 6 62,186 3 <0.001
Died within 12 Hours 8 575 1 60,279 2 0.690
Mortality Excl. Early Deaths 65 612 11 58,646 10 0.794
Total Mortality 110 611 18 61,366 14 0.009
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Deaths in the Delivery Room 2017
In 2017, a significantly higher proportion of ROI 
infants died in the delivery room (6%, n=37) 
compared to VON (3%, n=1,928; p<0.001). 
Similar statistically significant findings were 
obtained in the preceding years (Figure 6.2). 
The decreasing trend in ROI delivery room 
deaths from 2014, through to 2017 was, 
however, not statistically significant (p>0.05). 
Figure 6.2: Percentage of delivery room deaths between 2014 and 2017. 
Of the 37 infants who died in the delivery room 
in 2017, nine (24%) had a major congenital 
anomaly (Table 6.2). In total, 31 of 37 (84%) 
infants who died in the delivery room in the 
ROI in 2017 had either an MCA or were less 
than 24 weeks gestation. This is similar to the 
analogous proportions of 91% (32 of 35) in 
2016, 89% (39 of 44 infants) in 2015 and 86% 
(43 of 50 infants) in 2014. 
As previously mentioned in Section 2 (pg. 14), 
ROI infants were significantly more likely to 
be born with MCA compared to VON (8% in 
ROI compared to 5% VON in 2017) and this 
factor is very likely to have impacted on the 
higher delivery room death rate seen in the ROI 
population. 
A further 22 infants (59%), all of whom were 
born <24 weeks, died in the DR in 2017. Of 
these 22 infants, 6 were 21 weeks, 14 were 22 
weeks and two were 23 weeks gestation, none 

















2014	 2015	 2016	 2017	
ROI	 VON	
Table 6.2: Deaths in the delivery room, by gestational age category and presence of major congenital 
anomaly, 2017, n=37.





< 24 weeks 0 22 22
24-26 weeks 2 3 5
27-29 weeks 2 3 5
30-32 weeks 3 0 3
> 32 weeks 2 0 2
Total 9 28 37
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•  In 2017, the overall survival rate of VLBW 
infants born in Ireland was 82%. These 
values represent a marginal decrease of 2% 
in the survival rates for ROI infants when 
compared to 2015 and 2016 but is similar to 
the survival rate reported in 2014. 
•  Similar to previous years, a higher 
proportion of ROI infants died in the 
delivery room (6%, n=37) when compared 
to VON (3%, n=1,928; p<0.001).
•  The mortality risk in 2017 was consistent 
with the risk observed in the previous three 
years. It was 19% higher than expected 
after adjusting for the risk profile of the 
population (SMR 1.19; CI 0.96, 1.42); there 
were 14 more deaths than expected. The 
findings were similar when mortality 
excluding early deaths was considered 
(SMR=1.20; CI 0.93, 1.48).
•  There was an 84% elevated risk of 
Coagulase Negative infection reported in 
VLBW infants in ROI in 2014 and this has 
reduced to 16% in 2017 (RR 0.63; CI 0.39, 
1.01).
•  The risk of ROP among VLBW infants in 
ROI continues to be lower than expected, 
albeit by a smaller percentage in 2017 (SMR 
0.72; CI 0.99, 1.99) than in 2014 (SMR 0.51; 
CI 0.33, 0.70).
•  ROI Infants continue to show a statistically 
higher rate of pneumothorax compared to 
VON (SMR 1.69; CI 1.29, 2.1)
•  A statistically significant decrease in all 
KPIs was observed with higher gestational 
ages. This denotes a lower percentage of 
mortality, morbidity and specific outcomes 
(as measured in the KPIs) in infants born 
with higher gestational ages. 
•  Since 2014, there has been a steady 
increase in the number of infants born at 23 
weeks who are resuscitated in the delivery 
room (from 42% to 87%) and this had been 
associated with an increase in the number 
of these infants who survive to discharge 
(from 19% to 47%). 
•  A total of 22% of ROI infants <28 weeks 
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The National Office of Clinical Audit (NOCA) was established in 2012 to create sustainable 
clinical audit programmes at national level. NOCA enables those who manage and deliver 
healthcare to improve the quality of care through national clinical audit.
The NPEC aligns its audit governance structures to the NOCA audit governance standards 
for audit governance committees, monitoring & escalation of outliers and national reporting.
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Appendix A: Endorsement by the National 
Office of Clinical Audit (NOCA)
      
National Office of Clinical Audit 
2nd Floor 
Ardilaun House, Block B 
111 St Stephen’s Green 
Dublin 2, D02 VN51 




Dr Anne Twomey  
Consultant Neonatologist  
National Maternity Hospital  
Holles Street 
Dublin 2 
21st June 2019 
 
 
Re: Very Low Birth Weight Infants in the Republic of Ireland - Annual Report 2017 
 
 
Dear Dr Twomey,  
 
 
We thank you for the presentation by Professor Richard Greene and Dr Paul Corcoran to the NOCA 
Governance Board on Thursday the 6th of June.  
 
On behalf of the NOCA Governance Board and our Executive Team, I wish to congratulate you and 
your co-chair, Dr Brendan Murphy, the Neonatal Intensive Care Outcomes Research and Evaluation 
(NICORE) group and the National Perinatal Epidemiology Centre (NPEC) and all participating neonatal 
units for your combined efforts in initiating and supporting this valuable quality improvement 
initiative.  
 
Please accept this letter as formal endorsement from the NOCA Governance Board of the Very Low 







Professor Conor O’ Keane FFPath FRCPI 
Chair 
National Office of Clinical Audit Governance Board 
 
c.c. Dr. Anne Twomey, National Maternity Hospital, Holles Street, Dublin 2, Ireland  
Prof Richard Greene, National Perinatal Epidemiology Centre, CUMH, Cork 
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Appendix B: NICORE Group Members, 2017
Dr Muhammad Azam, Consultant Paediatrician, Wexford General Hospital
Dr Paula Cahill, Consultant Paediatrician, Portiuncula Hospital
Dr David Corcoran, Consultant Neonatologist, Rotunda Hospital
Dr Animitra Das, Consultant Neonatologist, University Hospital Waterford
Dr Rizwan Khan, Consultant Paediatrician, University Maternity Hospital Limerick 
Dr Alan Finan, Consultant Paediatrician, Cavan General Hospital
Dr Emma Gordon, Consultant Neonatologist, Our Lady of Lourdes Hospital
Dr Rizwan Gul, Consultant Paediatrician, Midland Regional Hospital Portlaoise
Dr Akhtar Khan, Consultant Paediatrician, University Hospital Kerry 
Dr Imelda Lambert, Consultant Paediatrician, Midland Regional Hospital, Mullingar
Dr Jan Miletin, Consultant Neonatologist, Coombe Women & Infants University Hospital
Dr Brendan Paul Murphy, Consultant Neonatologist, Cork University Maternity Hospital
Dr Donough O’Donovan, Consultant Neonatologist, University Hospital Galway
Dr Justin Roche, Consultant Paediatrician, South Tipperary General Hospital
Dr Hilary Stokes, Consultant Paediatrician, Mayo University Hospital
Dr Mathew Thomas, Consultant Paediatrician, Letterkenny University Hospital
Dr Hilary Greaney, Consultant Paediatrician, Sligo University Hospital
Dr Anne Twomey, Consultant Neonatologist, National Maternity Hospital
Dr David Waldron, Consultant Paediatrician, St. Luke’s General Hospital
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Appendix C: Vermont Oxford 
Network Data Collection Forms 
Rel 21.0                                              Copyright ©2016 Vermont Oxford Network, Inc.   All Rights Reserved.         1 
VERMONT OXFORD NETWORK 
PATIENT DATA BOOKLET FOR INFANTS BORN IN 2017 
Contents:
Page 1:          Patient Identification Worksheet  
Page 2:          Length of Stay Calculation Worksheet 
Page 3:          28 Day Form  
Pages 4 & 5:  Discharge Form (2 pages) 
Page 6:          Transfer and Readmission Form (only infants who transfer to another hospital) 
Page 7:          Supplemental Data Form (Expanded Database only) 
W1. Patient’s Name: _________________________________________
W2. Mother’s Name: _________________________________________ 
W3. Patient’s Medical Record Number: ________________________________ 
W4. Date of Birth:   _____/_____/_____ 
                MM         DD      YYYY 
W5. Date of Admission:  _____/_____/_____     For inborn infants, the date of admission is the Date of Birth.
         MM          DD       YYYY          For outborn infants, the date of admission is the date the infant was  
                    admitted to your hospital. 
W6. Date of Day 28:  ____/____/____
 MM      DD     YYYY      
W7. Date of Week 36:  ____/____/____
     MM      DD     YYYY    
W8. Date of Initial Disposition:  _____/_____/_____  
                                                                      MM           DD        YYYY       
W9. If Infant Transferred, Date Discharged Home, Died or First Birthday (if still hospitalized), 
         whichever is soonest:      _____/_____/_____ 
                                    MM            DD       YYYY  
PLEASE DO NOT SUBMIT THIS WORKSHEET
Protected Health Care Information
PATIENT IDENTIFICATION WORKSHEET 
This Worksheet contains protected health care information and must NOT be submitted to 
Vermont Oxford Network (VON). VON only accepts protected health care information in 
cases where members have both voluntarily elected to send this information to VON and 
have signed an appropriate Business Associate Agreement with VON.  
Network ID Number: Center Number:__________ 
Use the Calculation Charts for Date of Day 28  
and Date of Week 36 for the infant’s birth year. 
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Rel 21.0                                              Copyright ©2016 Vermont Oxford Network, Inc.   All Rights Reserved.         2 
SAMPLE CALCULATION OF INITIAL LENGTH OF STAY 
Enter Date of Initial Discharge, Transfer, or Death: 02 / 26 / 2017
Subtract Date of Admission:                                    01 / 13 / 2017                              ▬ 
 
Add 1:              +              
L1. INITIAL LENGTH OF STAY =                                          Days 
Explanation: Date of 02/26/2017 is Day Number 57.  Date of 01/13/2017 is Day Number 13.  The day numbers for 
each date are found in the 2017-2018 Day Number Chart on the Network web site, www.vtoxford.org.
     5   7 Day #
     1   3 Day # 
4   4 
          1 
4 5
                   
LENGTH OF STAY CALCULATION WORKSHEET
FOR INFANTS BORN IN 2017 
Protected Health Care Information. DO NOT SUBMIT this Worksheet to Vermont Oxford Network. 
Use items W5, W8, and W9 from the Patient Identification Worksheet when completing this form. 
Find the day numbers corresponding to dates using the Day Number Chart for 2016-2017 (www.vtoxford.org).
PLEASE DO NOT SUBMIT THIS WORKSHEET
Protected Health Care Information 
Part A. Initial Length Of Stay 
Enter Date of Initial Discharge, Transfer or Death (W8):  ____/____/____                                          Day # 
Subtract Date of Admission to Your Hospital (W5):         ____/____/____                    ▬           Day #
Add 1:                +   1 
                         
L1. INITIAL LENGTH OF STAY =             Days    
Note:  the maximum value of Initial Length of Stay is 366 (or 367 if leap day must be added), because tracking ends on the infant’s first birthday.
Part B. Total Length Of Stay 
Only For Infants Transferred From Your Hospital to Another Hospital. 
Enter Date of Final Discharge or Death (W9):                 ____/____/____                                       Day # 
Subtract Date of Admission (W5):                ____/____/____                  ▬        Day # 
 
Add 1:              +             1 
L2. TOTAL LENGTH OF STAY =            Days 
Note:  the maximum value of Total Length of Stay is 366 (or 367 if leap day must be added), because tracking ends on the infant’s first birthday.
Network ID Number:   Center Number:________
For inborn infants, the date of admission is the Date of Birth. 
For outborn infants, the date of admission is the date the infant was admitted to your hospital. 
For inborn infants, the date of admission is the Date of Birth. 
For outborn infants, the date of admission is the date the infant was admitted to your hospital. 
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 Rel 21.0                                              Copyright ©2016 Vermont Oxford Network, Inc.   All Rights Reserved.         3
28 DAY FORM - For Infants Born in 2017                      
Center Number: ________ Network ID Number:    Year of Birth:    ______ 
   1.  Birth Weight:    ________ grams   
   2.  Gestational Age:      a) Weeks   _______       b) Days (0-6) _______   
   3.  Died in Delivery Room:   Yes  No      (If Yes, Use Delivery Room Death Form.) 
   4.  a) Location of Birth:  Inborn  Outborn
        b) If Outborn, Day of Admission to Your Center (Range: 1 to 28.  Date of Birth is Day 1):  _______ 
        c) If Outborn, Transfer Code of Center from which Infant Transferred: __________ 
   (List available at http://www.vtoxford.org/transfers)
   5.  Head Circumference at Birth (in cm to nearest 10th):              
   6.  Maternal Ethnicity/Race  (Answer both a and b): 
     a) Ethnicity of Mother:  Hispanic     Not Hispanic   
   b) Race of Mother:  Black or African American   White        Asian       
      American Indian or Alaska Native  Native Hawaiian or Other Pacific Islander 
         Other 
   7.  Prenatal Care:   Yes  No 
   8.  Antenatal Steroids:    Yes  No    
   9.  Antenatal Magnesium Sulfate:  Yes  No    
  10.  Chorioamnionitis:   Yes  No 
  11.  Maternal Hypertension, Chronic or Pregnancy-Induced:            Yes  No
  12.  Mode of Delivery:  VaginaI  Cesarean Section 
  13.  Sex of Infant:    Male  Female 
  14.  a) Multiple Gestation:  Yes  No     b)  If Yes, Number of Infants Delivered:  _____ 
  15.  APGAR Scores:   a) 1 minute _______      b) 5 minutes _______
  16.  Initial Resuscitation:       a) Oxygen:    Yes  No        
       b) Face Mask Vent:  Yes  No 
      c) Endotracheal Tube Vent:  Yes  No        
      d) Epinephrine:  Yes  No 
      e) Cardiac Compression:  Yes  No 
      f ) Nasal CPAP:   Yes  No
  17.  a) Temperature Measured within the First Hour after Admission to Your NICU:     
                                                               Yes       No             N/A 
         b) If Yes, Temperature Within the  First Hour after Admission to Your NICU
(in degrees centigrade to nearest 10th):            
  18.  Bacterial Sepsis on or before Day 3:                   Yes           No 
  19. Oxygen on Day 28:     Yes                       No            N/A (See Manual for N/A criteria)
  20.  Periventricular-lntraventricular Hemorrhage (PIH): 
         a) Cranial Imaging (US/CT/MRI) on or before Day 28:           Yes               No
         b) If Yes, Worst Grade of PIH (0-4):           _______ 
         c) If PIH Grade 1-4, Where PIH First Occurred:           Your Hospital      Other Hospital      N/A    














    
   22. Respiratory Support (at any time after leaving the delivery room/initial resuscitation area):
  a) Oxygen after Initial Resuscitation:      Yes   No
   b) Conventional Ventilation after Initial Resuscitation:  Yes   No
  c) High Frequency Ventilation after Initial Resuscitation:   Yes   No
         d) High Flow Nasal Cannula after Initial Resuscitation:   Yes   No
  e) Nasal IMV or Nasal SIMV after Initial Resuscitation:   Yes   No
     23.    a) Nasal CPAP after Initial Resuscitation:     Yes   No
              b) NCPAP before or without ever having received ETT Vent:  Yes   No  N/A
     24.    a) Surfactant during Initial Resuscitation:  Yes    No 
                        b) Surfactant at Any Time:       Yes    No (Item 24.b must be Yes if Item 24.a is Yes)
            If Yes, Age at First Dose:    c) Hours _____ d) Minutes (0-59) _____  
     25.   a) Inhaled Nitric Oxide:      Yes  No 
          b) If Yes, where given:      Your Hospital      Other Hospital      Both 
     26.   Respiratory Support at 36 Weeks (See Manual for N/A criteria):
          a)  Oxygen at 36 Weeks:     Yes    No  N/A    
 b)  Conventional Ventilation at 36 Weeks:  Yes    No  N/A 
 c)  High Frequency Ventilation at 36 Weeks:  Yes    No  N/A
 d)  High Flow Nasal Cannula at 36 Weeks:  Yes    No  N/A
 e)  Nasal IMV or SIMV at 36 Weeks:   Yes    No  N/A
 f)   Nasal CPAP at 36 Weeks:           Yes    No  N/A
     27.    a)  Steroids for CLD:            Yes  No 
          b)  If Yes, Where Given:     Your Hospital      Other Hospital      Both     
     28.  Indomethacin for Any Reason:    Yes    No
            29.  Ibuprofen for PDA:     Yes   No        
            30.  Probiotics:      Yes   No        
            31.  Treatment of ROP with Anti-VEGF Drug:  Yes   No        
      32. a) ROP Surgery:        Yes    No
        b) If Yes, Where Done:      Your Hospital      Other Hospital      Both     
     33. a) PDA Ligation:         Yes    No 
                b) If Yes, Where Done:      Your Hospital      Other Hospital      Both 
     34. Surgery for NEC, Suspected NEC, or  Yes   No (If Yes, a Surgery Code is Required in item 36a)
             Bowel Perforation: 
     35. Other Surgery:      Yes    No (If Yes, a Surgery Code is Required in item 36a)
36a. If Yes to NEC Surgery or Other Surgery, Surgical Codes (See Appendix D): If NEC Surgery, one or          
more of the following codes is required: S302, S303, S307, S308, S309, S333. Indicate location of surgery for each surgery code.
   Surgery Code 1: ____________  Your Hospital Other Hospital Both 
 Surgery Code 2: ____________  Your Hospital Other Hospital Both 
 Surgery Code 3: ____________  Your Hospital Other Hospital Both 
 Surgery Code 4: ____________  Your Hospital Other Hospital Both 
 Surgery Code 5: ____________  Your Hospital Other Hospital Both 
 Surgery Code 6: ____________  Your Hospital Other Hospital Both 
 Surgery Code 7: ____________  Your Hospital Other Hospital Both 
 Surgery Code 8: ____________  Your Hospital Other Hospital Both 
 Surgery Code 9: ____________  Your Hospital Other Hospital Both 
 Surgery Code 10: ___________  Your Hospital Other Hospital Both 
36b. Include description for codes S100,S200,S300,S400,S500,S600,S700,S800,S900,S1000&S1001: 
  DISCHARGE FORM - For Infants Born in 2017 - Page 1               
Center Number: ________ Network ID Number:                       Year of Birth:    _______
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DISCHARGE FORM - For Infants Born in 2017 - Page 2                
Center Number: ________ Network ID Number:                      Year of Birth:    _______ 
     
    37. Respiratory Distress Syndrome:    Yes     No 
    38. a) Pneumothorax:                                   Yes       No 
               b) If Yes, Where Occurred:     Your Hospital      Other Hospital      Both    
        39. Patent Ductus Arteriosus:               Yes     No 
      40. a) Necrotizing Enterocolitis:         Yes     No 
              b) If Yes, Where Occurred:     Your Hospital      Other Hospital      Both    
      41. a) Focal Intestinal Perforation:        Yes  No 
               b) If Yes, Where Occurred:     Your Hospital      Other Hospital      Both    
            Sepsis and/or Meningitis, Late (after day 3 of life): (See Manual for N/A criteria)
     42. a) Bacterial Pathogen:               Yes     No        N/A 
                 b) If Yes, Where Occurred:  Your Hospital  Other Hospital     Both
     43. a) Coagulase Negative Staph:     Yes    No         N/A 
                   b) If Yes, Where Occurred:     Your Hospital  Other Hospital     Both
     44. a) Fungal Infection:                      Yes     No         N/A
                   b) If Yes, Where Occurred:     Your Hospital  Other Hospital     Both
     45. Cystic Periventricular Leukomalacia:              Yes     No        N/A (see Manual for N/A criteria) 
     46. ROP:  a) Retinal Exam Done:       Yes     No 
                    b) If Yes, Worst Stage of ROP (0-5):         _____ 
     47. Major Birth Defect:       Yes    No
         If Yes, enter codes:    _____   _____   _____   _____   ____ 
           Include description for Codes 100, 504, 601, 605, 901, 902, 903, 904 & 907:
     48. Enteral Feeding at Discharge:
            None 
            Human Milk Only
            Formula Only
            Human milk in combination with either fortifier or formula      
     49. Oxygen and Monitor at Discharge: 
         a) Oxygen at Discharge:           Yes  No
         b) Monitor at Discharge:          Yes  No 
     50. Initial Disposition (check only one): 
           Home 
           Died 
           Transferred to another Hospital    (       Complete Transfer and Readmission Form)  
           Still Hospitalized as of First Birthday 
    51. Weight at Initial Disposition: _________ grams 
    52. Head Circumference at Initial Disposition (in cm to the nearest10th):
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TRANSFER & READMISSION FORM - For Infants Born in 2017
Center Number: ________ Network ID Number:    Year of Birth:    ______ 
Part A.  Complete for ALL Transferred Infants 
If an infant is transferred to another hospital, complete Items 54 - 56. Post Transfer Disposition (Item 56) refers to the  
infant's disposition upon leaving the "transferred to" hospital.  
54. Reason for Transfer:  Growth/Discharge Planning  Medical/Diagnostic Services  
       Surgery ECMO  Chronic Care  Other  
55. Transfer Code of Center to which Infant Transferred: _______ (List available at https://www.vtoxford.org/tools/transferlist.aspx)
   56. Post Transfer Disposition (check only one): 
Home         Skip Parts B and C. Complete Part D. 
    Transferred Again to Another Hospital (2nd Transfer) Skip Part B. Complete Parts C and D when data are available.
       Died       Skip Parts B and C. Complete Part D.
    Readmitted to Any Location in Your Hospital   Complete Parts B and D (and C if applicable) when data are available.
    Still Hospitalized as of First Birthday   Skip Parts B and C. Complete Part D. 
Part B.  Complete ONLY for Readmitted Infants 
If a patient is readmitted to your center after transferring once to another hospital without having been home, answer 
Items 57 - 58.  When infants are readmitted to your center, continue to update Items 18 - 20 on the 28 Day Form, and 
Items 22 – 49 on the Discharge Form based on all events at both hospitals until the date of Disposition after 
Readmission.  If your hospital participates in the Expanded Database and definition criteria are met, update Items 
S1.B, S1.C.1, S1.C.2, S2.A.1, S2.A.2 and S2.C based on events that occur following transfer and readmission.
57. Disposition after Readmission (check only one): 
    Home         Skip Part C. Complete Part D. 
    Died         Skip Part C. Complete Part D. 
    Transferred Again to Another Hospital     Complete Parts C and D when data are available.  
    Still Hospitalized as of First Birthday      Skip Part C. Complete Part D. 
58. Weight at Disposition after Readmission:  _________ grams
Part C.  Complete ONLY for Infants Who Transferred More Than Once 
Answer Item 59 if an infant transferred from your center to another hospital and was then either (1) transferred again to 
another hospital, or (2) readmitted to your center and then transferred again to another hospital.  
59. Ultimate Disposition (check only one): 
    Home         Complete Part D. 
    Died         Complete Part D.  
    Still Hospitalized as of First Birthday      Complete Part D.
Part D. Complete for ALL Transferred Infants 
Complete Item 60 when the infant has been discharged Home, Died or is Still Hospitalized as of First Birthday, 
whichever comes first. 
60.   Total Length of Stay:  ________day(s)    (Item L2 on Length of Stay Calculation Worksheet) 
(Check Only One)
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VERMONT OXFORD NETWORK
DELIVERY ROOM DEATH BOOKLET FOR INFANTS BORN IN 2017 
Contents:
Page 1:  Patient Identification Worksheet
Page 2:  Delivery Room Death Form  
W1. Patient’s Name: ________________________________________
W2. Mother’s Name: _________________________________________
W3. Patient’s Medical Record Number: ________________________________
W4. Date of Birth:  _____/_____/_____ 
                        MM          DD            YYYY 
PLEASE DO NOT SUBMIT THIS WORKSHEET 
Protected Health Care Information 
DELIVERY ROOM DEATH  
PATIENT IDENTIFICATION WORKSHEET 
Use the Delivery Room Death Booklet for eligible inborn infants who die in the 
delivery room or at any other location in your hospital within 12 hours of birth and 
prior to admission to the NICU.
This Worksheet contains protected health care information and must NOT be 
submitted to Vermont Oxford Network (VON). VON only accepts protected 
health care information in cases where members have both voluntarily elected 
to send this information to VON and have signed an appropriate Business 
Associate Agreement with VON.
Network ID Number:Center Number: _______
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DELIVERY ROOM DEATH FORM – For Infants Born in 2017
Center Number:  ________   Network ID Number:                   Year of Birth:  ________
   
    1.  Birth Weight:                                    ________ grams   
    2.  Gestational Age:   a) Weeks _____ b) Days (0-6) _____ 
    3.  Died in Delivery Room:  Yes   No  (If NO, do not use this Form)
    4.   a) Location of Birth:  Inborn  Outborn (If OUTBORN, do not use this Form)
          b and c:  Not Applicable 
    5.  Head Circumference at Birth (in cm to the nearest 10th):                     
    6.  Maternal Ethnicity/Race:  (Answer both a and b): 
 a) Ethnicity of Mother:  Hispanic    Not Hispanic  
    b) Race of Mother:  Black or African American        White  Asian       
      American Indian or Alaska Native   Native Hawaiian or Other Pacific Islander 
          Other 
    7.  Prenatal Care:            Yes  No 
    8.  Antenatal Steroids:           Yes    No 
    9.  Antenatal Magnesium Sulfate:      Yes    No 
  10.  Chorioamnionitis:           Yes  No  
  11.  Maternal Hypertension, Chronic or Pregnancy-Induced:               Yes   No 
  12.  Mode of Delivery:           Vaginal  Cesarean Section 
  13.  Sex of Infant:            Male  Female 
  14.  a) Multiple Gestation:           Yes  No b) If Yes, Number of Infants Delivered:    ______ 
  15.  APGAR Scores:            a) 1 minute _____ b) 5 minutes  _____  
  16.  Initial Resuscitation: a) Oxygen:                Yes   No   
      b) Face Mask Vent:               Yes   No 
c) Endotracheal Tube Vent:  Yes   No   
      d) Epinephrine:  Yes     No 
e) Cardiac Compression:  Yes   No 
     f)  Nasal CPAP:   Yes   No 
    17 – 23:  Not Applicable 
  24.  Surfactant Treatment: 
         a) Surfactant during Initial Resuscitation:      Yes     No  
           b) Surfactant at Any Time:      Yes     No  (Part b must be answered “Yes” if Part a is “Yes”)
         If Yes, Age at First Dose:             c) hours ______  d) minutes (0-59) ______   
    25 – 46:  Not Applicable 
            47.  Major Birth Defect:      Yes      No If Yes, enter codes ______  ______  ______  ______  _______ 
Include description for Codes 100, 504, 601, 605, 901, 902, 903, 904 & 907:  __________________________ 
    __________________________________________________________________________________________ 
▪
  48 – 60:  Not Applicable
If your center participates in the Expanded Database, answer Items S2. B.1 and S2. B.2 from the 
Supplemental Data Form.  Items S1.A. to S1.C. and Items S2.A and S2.C are not applicable. 
S2. B. 1. Meconium Aspiration:                                                               Yes                     No 
      B. 2. Tracheal Suction for Meconium Attempted in the DR:           Yes                     No  N/A 
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Appendix D: VON unit leads and co-ordinators 
and contributors 2017
Neonatal Unit Leads Co-ordinators
Cavan General Hospital Dr Alan Finan Dr Alan Finan 
Coombe Women and Infants University Hospital Dr John Kelleher Ms Julie Sloan
Cork University Maternity Hospital Dr Brendan Paul Murphy Dr Brendan Paul Murphy
Kerry General Hospital, Tralee Ms Margaret Kelly Dr Akhtar Khan
Letterkenny General Hospital — Dr Mathew Thomas 
Mayo General Hospital, Castlebar Dr Hilary Stokes Dr Hilary Stokes
Midland Regional Hospital, Mullingar — Dr Imelda Lambert
Midland Regional Hospital, Portlaoise Dr Anne Doolan Dr Rizwan Gul
Mid-Western Regional Maternity Hospital, Limerick Dr Niazy Al-Assaf Ms Therese O Donoghue
National Maternity Hospital, Dublin Dr Anne Twomey Dr Finola Byrne
Our Lady of Lourdes Hospital, Drogheda Claire Shannon Claire Shannon
Portiuncula Hospital, Ballinasloe Dr Paula Cahill Dr Paula Cahill
Rotunda Hospital, Dublin Ms Kathy Conway Dr Breda Hayes
Sligo General Hospital Dr Hilary Greaney Dr Hilary Greaney
South Tipperary General Hospital, Clonmel — Dr Justin Roche
St Luke’s Hospital, Kilkenny Dr David Waldron Dr David Waldron
University Maternity Hospital Limerick Niazy Al-Assaf Betty Reidy
University Hospital Galway Dr Donough O’Donovan Dr Donough O’Donovan
Waterford Regional Hospital Dr Animitra Das Dr Animitra Das
Wexford General Hospital Dr Muhammad Azam Dr Naeem Aziz Shori 

National Perinatal Epidemiology Centre, 
Department of Obstetrics and Gynaecology, UCC, 
5th Floor, Cork University Maternity Hospital,  
Wilton, Cork, Ireland. 
Tel: +353 21 4205017  
Email: npec@ucc.ie  
www.ucc.ie/en/npec/
